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Adaptation of the bacterial CRISPR-Cas9 system to mammalian cells 
revolutionized the field of functional genomics, enabling genome-scale genetic 
perturbations to study essential genes, whose loss of function results in a severe 
fitness defect. There are two types of essential genes in a cell. Core essential genes 
are absolutely required for growth and proliferation in every cell type. On the other 
hand, context-dependent essential genes become essential in an environmental or 
genetic context. The concept of context-dependent gene essentiality is particularly 
important in cancer, since killing cancer cells selectively without harming surrounding 
healthy tissue remains a major challenge. The toxicity of traditional cancer treatment 
protocols to the normal cells stresses the need for new strategies that can identify and 
address the weaknesses specific to cancer cells.  
 
Studies showed that CRISPR monogenic knockout screens can identify 
specific processes that cells rely on for growth and proliferation, which is a crucial step 
in identifying candidate cancer-specific therapeutic targets. While it is widely accepted 
that CRISPR screening is both more specific and more sensitive than previously 




In this dissertation, through several lines of integrated analysis of CRISPR 
screen data in cancer cell lines from the Cancer Dependency Map initiative, I will 
describe several computational approaches to demonstrate that CRISPR screens are 
not saturating. In fact, a typical screen has a ~20% false-negative rate, saturating 
coverage requires multiple repeats and false negatives are more prevalent among 
moderately expressed genes. I will then introduce a solution to the false negative 
problem and describe another method that provides a cleaner analysis of the data, 
rescuing the false negatives observed in these screens. Moreover, I will show that half 
of all constitutively expressed genes are never observed as essential in any CRISPR 
screen. Notably, these never-essentials are highly enriched for paralogs, suggesting 
that functional redundancy masks detection of a substantial number of genes. Finally, 
I will describe our efforts to investigate functional buffering among approximately 400 
candidate paralog pairs using CRISPR/enCas12a dual-gene knockout screening 
technology and discuss the paralog synthetic lethal interactions that we have 
identified, which have escaped detection in monogenic CRISPR-Cas9 knockout 
screens. Collectively, these observations reveal significant biases and blind-spots in 
the analysis of CRISPR-based functional genomics approaches and offer new 
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Chapter 1:  Introduction  
 
1.1 Essential Genes 
1.1.1 Gene essentiality in cell lines 
The concept of gene essentiality has been a fundamental idea in genetics, with 
the ultimate goal of defining a set of genes that are indispensable for life. Therefore, 
it is important to make it explicit how essentiality is defined in this study. If we look at 
gene essentiality from an organismal level, an organism has all the required set of 
essential genes in all tissues. If there is a loss of function in these essential genes, 
this may either result in death during organismal development or may prevent the 
reproduction and growth of that organism into a sexually mature adult. This definition 
of essentiality is rather rigid since some genes might become essential under specific 
conditions . It is evident that while there is a strict set of essential genes the loss of 
which results in lethality, especially in multicellular organisms, there is also a larger 
set of genes that are only required during certain developmental stages or in different 
tissue types. For example, the International Mouse Phenotyping Consortium (IMPC) 
has conducted a large-scale effort to identify essential genes in mice. By generating 
a genome-wide set of gene knockouts in mice, IMPC has identified 410 genes whose 
knockout led to an embryonic lethal phenotype (The International Mouse Phenotyping 
Consortium et al., 2016). The same study also identified a broader set of 3,326 
essential genes to include genes whose loss resulted in a “sub-viable” phenotype 
based on observed phenotypes in different tissues. Furthermore, in a study that 
focused on 2,700 essential genes in C.elegans, the researchers revealed that post-
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developmental inactivation of 64 genes actually resulted in an increased lifespan 
(Curran and Ruvkun, 2007). 
 
In this study, we are looking at gene essentiality at a cellular level and at this 
level essential genes can be defined as the genes required for cellular growth and 
proliferation and if they are lost, you observe a fitness defect. An alternative concept 
that is similar to essentiality is fitness. While gene essentiality is mainly considered at 
the individual cell level, fitness is a phenomenon observed in a population, where each 
gene has a partial contribution to the overall fitness. Fitness can be defined as the 
quantification of the relative proliferation rate of a certain population compared to its 
wild type counterpart. This concept was demonstrated in yeast studies, where the 
fitness of each deletion strain under a specific condition is compared to the strain 
without the deletion under the same environmental condition (Hillenmeyer et al., 
2008). Because fitness is a population level metric, it is possible that genes that cause 
reduced fitness cannot be detected within a single generation because they don’t 
result in immediate cell death. However, in a heterogenous population which is 
monitored over multiple generations, negative selection against genes that show even 
mild fitness defects over consecutive generations will be detectable at the population 
level, as the cells that carry the fitness defects will drop out from the population over 
time (Arun K. Ramani et al., 2012; Zhan and Boutros, 2016). Therefore, within a 




1.1.2 Types of essential genes – Daisy model 
 
A very useful model that explains different types of essential genes and serves 
as a foundation to many ideas in this dissertation is the Daisy Model of Gene 
Essentiality that has been proposed previously (Hart et al., 2015, 2014). In this model, 
the essential genes in a cell line or a genetic context is represented by the petals of 
the daisy (Figure 1.1). The petals of the flower show overlap to differing degrees but 















Context  B Context  A 
 Context   
      C 
Figure 1.1: Daisy model of gene essentiality. Essential genes in different contexts are 
represented by the petals of the flower, and all petals share the common core set of essential 
genes which are essential across all contexts. 
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The core fitness genes shared by all petals represent the universally essential 
genes that are expected to be present at all contexts. This model is very helpful for a 
couple of purposes. First, it helps to define a set of essential genes that are commonly 
essential across every cell line or possible context. These universally essential genes 
represent the core cellular machinery of the cell such as transcription, translation, DNA 
replication and several other processes required for cellular growth and propagation. 
Second, these genes provide a control mechanism to evaluate the quality of a screen 
to detect these essential genes, since in every whole genome screen performed, one 
should expect to detect all these essential genes. The lack of observation of these 
genes as essential would indicate a technical or experimental problem in the screen 
and caution needs to be applied during the interpretation of the results.  
 
1.1.3 Context-specific gene essentiality 
 
An important implication of the daisy model is that gene essentiality is not 
binary in nature and that it depends on environmental conditions. In the model, we 
can observe that even though all petals share a common core set of essential genes, 
there are also sets of another group of essential genes called context-essential genes 
that become essential only in certain conditions, reflecting the context-dependent 
nature of gene essentiality. This phenomenon has been observed in previous studies 
in model organisms to identify essential genes. In a landmark yeast study, ~5000 
homogenous and ~6000 heterogeneous deletion strains were generated, and after 
these strains were exposed to different environmental stress conditions as well as to 
hundreds of small molecules, and their fitness phenotypes were measured 
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(Hillenmeyer et al., 2008). Strikingly, the researchers observed that among ~6000 
deletion strains, 97% showed an essential phenotype indicated by a significant growth 
defect when deleted. A similar study in bacteria investigated >10,000 phenotypes 
generated by testing ~ 4000 bacterial mutants in more than 300 hundred conditions 
(Nichols et al., 2011). This study also showed that many putative non-essential genes 
are actually required for growth and observed as essential in at least one of the 
environmental conditions tested in the study. 
 
Delineating and differentiating core essential genes from context essential 
genes is especially important in understanding pathophysiology of human diseases 
especially tissue specific pathologies. In the context of cancer for example, 
identification of differentially essential genes in tumor cells but not in surrounding 
healthy tissue can ultimately lead to development of highly effective therapeutic 
agents with no significant side effects. This posits the need for the identification of 
human essential genes. 
 
1.1.4 Human gene essentiality 
 
The identification of essential genes in human cells mainly depends on studies 
that monitor genes whose loss creates a growth and proliferation defect phenotype in 
human cancer cells lines grown under laboratory conditions for multiple generations. 
Even though cancer cells undergo multiple genomic alteration events, the main 
machineries that are responsible for growth and proliferation both in cancer cells and 
healthy human cells are expected to be the same across both instances. However, 
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the main driving motivation for the efforts to identify essential genes in cancer cells 
has been to pinpoint the essential genes that are differentially essential in human 
cancer cells so that novel therapeutics could be designed to target these cancer 
specific dependencies. This notion has been explained in the Daisy Model of gene 
essentiality described above (Figure 1.1), with the petals representing cancer specific 
essential genes in different cancer types. Even though this concept seems quite 
straightforward and easy to grasp, the development of appropriate tools to 
systematically assay and evaluate organismal level gene essentiality across the entire 
genome has been limited by the technologies available. Some earlier methodologies 
include alkylating agent based chemical mutagenesis screens in mice (de Angelis et 
al., 2000), insertion of transposable elements in Drosophila genes (Bellen et al., 2004), 
utilization of RNAi technology to conduct genome-wide RNAi screens in multiple 
organisms (Dietzl et al., 2007; Kamath et al., 2003; Meister and Tuschl, 2004; Moffat 
and Sabatini, 2006). Most recently, developments in genome editing by the discovery 
of CRISPR-Cas9 system and its application to mammalian cells (Shalem et al., 2014; 
Wang et al., 2014) enabled a huge breakthrough in human functional genomics 
research by enabling systematic genome-scale approaches to unravel human 
essential genes. Some of these advances will be discussed in the next sections. 
 
1.2 Identification of essential genes using RNA 
interference (RNAi) 
 
RNA silencing or RNA interference is an essential regulator of gene silencing 
in eukaryotic organisms. This pathway was first discovered in plants as an antiviral 
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protection mechanism to prevent the organisms from the integration of transposable 
elements and RNA viruses (Waterhouse et al., 2001). RNAi regulates gene 
expression through specific genes that code for short double stranded RNAs 
(dsRNAs) that are precursors for small interfering RNAs (siRNAs). These siRNAs 
carry sequence homology to the mRNA transcript that is intended for silencing and 
thus determines which transcript will be targeted (Meister and Tuschl, 2004). Besides 
this innate mechanism to protect against viruses, it was later shown that exogenous 
introduction of dsRNAs is capable of achieving gene expression knockdown first in C. 
elegans (Fire et al., 1998) and later in D. melanogaster embryos (Kennerdell and 
Carthew, 1998). 
 
1.2.1 Small interfering RNA (siRNA) 
 
Studies about the components of the RNAi mechanism showed that the main 
regulators are conserved across multiple different organisms. Small RNAs are 
produced in a stepwise fashion by two separate dsRNA-specific RNase-III-type 
endonucleases called Drosha and Dicer. During the initial step, Drosha nuclease plays 
a role in the nuclear processing of long primary transcripts called pri-miRNA 
precursors by cutting and creating overhangs on their stems-loops to create ~70 
nucleotide long pre-miRNAs (Lee et al., 2003). After this process, these pre-miRNAs 
get transported to the cytoplasm through exportin-5 (Lund, 2004; Yi, 2003). In the 
cytoplasm, the pre-miRNAs get cleaved by Dicer to generate ~22 nucleotide long final 
products called siRNAs with overhangs on both 5’ and 3’ ends (Bernstein et al., 2001; 
Elbashir, 2001). The ribonucleoprotein particles (RNPs) that contain the siRNAs get 
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reassembled into a multi-component RNA-induced silencing complex (RISC) that has 
sequence-specific nuclease activity (Bernstein et al., 2001; Hammond et al., 2000). 
This RISC complex includes the siRNA, Dicer as well as the Argonaute (Ago) protein 
in its core which binds tightly to the RNA to unwind the siRNA (Hammond, 2001; 
Okamura, 2004). After the assembly of the RISC complex, the single stranded siRNA 
within the complex guides it to the target mRNA, which is complementary or near-
complementary in sequence to the siRNA (Martinez et al., 2002). The target mRNA 
then gets cleaved by Ago proteins which results in rapid degradation of the cleaved 
mRNA and gene silencing (Meister and Tuschl, 2004; Tuschl et al., 1999; Zamore et 
al., 2000).  
 
Using this innate mechanism, researchers discovered that the dsRNA that is 
needed for RNAi can be externally introduced into cells in order to achieve gene 
knockdown. In model organisms, methods such as direct injection of embryos with 
dsRNA (Fire et al., 1998; Kennerdell and Carthew, 1998) and transfection of cell lines 
with long dsRNAs (Clemens et al., 2000; Hammond et al., 2000) were applied to 
investigate mutant phenotypes. Even though the introduction of these long dsRNAs 
was easily accomplished in these model organisms, similar efforts in mammalian cells 
have proven to be much more challenging due to the activation of the antiviral immune 
response through induction of interferon-linked pathways when dsRNAs longer than 
30 nucleotides are used (Rana, 2007). Fortunately, later studies showed that the 
shorter 21 nucleotide long synthetic siRNAs are capable of inhibiting expression of 
genes in mammalian cells without eliciting cytotoxic immune response (Caplen et al., 
 9 
2001; Elbashir et al., 2001). After these studies, using siRNA became the standard 
procedure in functional genomics to provide valuable insights into detection of fitness 
genes.  
 
In a landmark pilot study, 21 genes were targeted by 21 nucleotide long siRNAs 
to identify essential genes that impaired cellular growth post RNA interference, 
showing that siRNA could be used to screen mammalian cells (Harborth et al., 2001). 
A later larger scale effort used 5305 siRNAs to study genes necessary for cellular 
division in HeLa cells (Kittler et al., 2004). Some of the siRNAs used in this study 
targeted proteins that regulate core machineries of the cell and hence showed that 
knockdown of these essential ribosomal and proteasomal proteins resulted in a 
significant fitness defect in cells. 
 
1.2.2 Short hairpin RNA (shRNA) 
 
One major disadvantage of the siRNA based gene interference is that the 
instability of the siRNA limits the utility of this system to transient in vitro studies. 
Moreover, the system is problematic for cells with low transfection efficiencies which 
results in incomplete transfection and therefore incomplete knockdown. To address 
these limitations, short hairpin RNAs (shRNAs) were developed which can be 
processed by Dicer to transform into siRNAs. The resulting siRNAs can then bind to 
target mRNA through incorporation into the RISC complex. Although the shRNAs can 
be transfected into cells like siRNA, creating a stable shRNA cell line is an arduous 
and time-consuming task as selection of shRNA positive cells usually takes months. 
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Therefore, expression through mammalian expression vectors or for cells that are not 
easily transfectable, using adenoviral or lentiviral vectors with shRNA expressing 
cassettes and transducing cells with packaged virus are more efficient methods for 
successful delivery of shRNAs (Abbas-Terki et al., 2002; Brummelkamp, 2002). 
Especially lentivirus mediated shRNA delivery has been shown to enable stable and 
long-term gene knockdown in rapidly dividing as well as dormant mammalian cells 
(Manjunath et al., 2009). 
 
shRNAs contain a 21-29 nucleotide long siRNA sequence, a loop section, the 
reverse complement of the siRNA region and a short terminator sequence. While 
shRNAs can be expressed using plasmid based systems using RNa polymerase III 
(pol III) promoters without triggering interferon responses, the most widely used pol III 
promoters are the U6 promoter and the H1(Brummelkamp, 2002; Kawasaki, 2003; 
Lee et al., 2002). During transcription, the shRNA transcripts gets organized in a 
hairpin structure by folding on itself and gets processed by Dicer (Dykxhoorn et al., 
2003). 
 
1.2.3 Functional genetic screens using RNAi technology 
 
Some of the initial loss of function shRNA screens were conducted in a pooled 
format. In pooled loss of function screens, the plasmids containing the shRNA library 
gets packaged into lentiviral vectors and then the lentiviral stocks are transduced into 
cells using a low multiplicity of infection (MOI) to prevent multiple viral integrations per 
cell. The cells that are transduced are selected using an antibiotic selection and are 
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grown for multiple doublings under a specific condition. At each passaging time point, 
cells are frozen in order to extract shRNA sequences at the end of the assay so that 
the relative abundance of the shRNA populations can be quantified compared to the 
initial time point using next generation sequencing (Luo et al., 2008). This pooled 
screening methodology has been extremely useful for the identification of essential 
genes in a systematic way as the shRNAs targeting essential genes are expected to 
be depleted from the population over time. One study used an RNAi library with 23,742 
unique shRNAs targeting 7,914 different human genes for knockdown in order to 
identify regulators of p53 dependent proliferation arrest (Berns et al., 2004). When the 
RNAi Consortium (TRC) was founded, an initial TRC library was constructed targeting 
both mouse and human genes to determine essential genes for mitotic progression 
and proliferation (Moffat et al., 2006). Later, a more extensive version of the TRC 
library that included 170,000 shRNAs targeting 17,200 genes was used in a high-
throughput manner to identify essential genes in 12 different cancer cell lines (Luo et 
al., 2008). Another study used shRNA pools of different scales ranging from 6,000 to 
20,000 shRNAs to investigate fitness genes in 5 cell lines from human mammary 
tissue (Silva et al., 2008). Multiple loss of function shRNA screens conducted by 
different groups pinpointed sets of core dependencies that are essential in all cell 
lines. These core essential genes were found to be enriched in processes related to 
the core machineries of the cell such as transcription, translation, proteosome, mRNA 
splicing, ribosome, cell cycle regulators and other housekeeping genes (Kittler et al., 
2004; Luo et al., 2008; Schlabach et al., 2008; Silva et al., 2008).  
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One important observation from these screens was that how the cells tolerated 
the knockdown of the essential genes showed differences between different cell lines. 
In one shRNA study that targeted 2924 genes in 4 cell lines, it was observed that the 
number of essential genes showed variance between cell lines (ranging from 3% to 
23.8 of the genes tested) and that several genes were differentially essential in 
specific backgrounds (Schlabach et al., 2008). Therefore, besides identification of 
core essential genes, shRNA screens were also used in order to find context 
dependent essential genes in different backgrounds. This idea is very significant in 
the context of cancer since context dependent essential genes in cancer cells 
represent genomic vulnerabilities that can potentially be targeted with novel 
therapeutic agents. Studies showed that a subgroup of colorectal cancer cell lines 
showed dependency on a specific KRAS mutation for growth and survival (Shirasawa 
et al., 1993). After these studies, the term “oncogene addiction” was developed, which 
describes the dependency of cancer cells on particular oncogenes for continuous 
growth and proliferation (Weinstein and Joe, 2008). Several RNAi screens were then 
performed on small arrays of cancer cells to search for these oncogenic essentials 
(Moffat et al., 2006; Schlabach et al., 2008; Silva et al., 2008). Some examples of 
these context specific essential genes are the IRF4 transcription factor in multiple 
myeloma cell lines (Shaffer et al., 2008), Brd4 in a mouse model of acute myeloid 
leukemia (AML) (Zuber et al., 2011) and BCR-ABL dependency in K562 chronic 
myelogenous leukemia (CML) cell line (Luo et al., 2008). 
 
 13 
Based on the promising results from these studies towards identification of 
therapeutically targetable cancer-specific vulnerabilities, Project Achilles was 
launched to characterize essential genes using an shRNA library with 11,000 genes 
across 216 human cancer cell lines (Cowley et al., 2014). Similarly, another relatively 
large scale study in 72 cell lines from pancreatic, ovarian and breast cancer tissues 
(Marcotte et al., 2012) revealed concordant results with a similar study (Cheung et al., 
2011), indicating confidence in the methodology. With development of improved 
computational approaches in the analysis of genome-wide loss of function screens, 
an initial set of 291 core essential genes were identified across 48 cell lines (Hart et 
al., 2014). In 2017, Cancer Dependency Map effort was initiated at the Broad Institute 
to predict and map cancer dependencies using data from genome-scale shRNA 
screens from 501 cell lines (Tsherniak et al., 2017). This study identified 769 
differentially essential genes across the cell lines screened in the study. In a similar 
large-scale effort to identify therapeutic targets, Project DRIVE (Deep RNAi 
Interrogation of Viability Effects in cancer) assessed 7,837 genes for dependencies 
using a lentiviral shRNA library of a median  of 20 shRNAs per gene across 398 cancer 
cell lines (McDonald et al., 2017). Project DRIVE also identified tissue specific 
oncogenes, synthetic lethal interactions, lineage-specific transcriptional factors as well 
as genetic interaction networks. 
 
1.2.4 Disadvantages of the RNAi technology 
 
The RNAi technology provided a lot of valuable insights for elucidating gene 
function and characterizing essential genes. However, the popularity of the method 
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diminished as several significant disadvantages were identified. Even though 
significant efforts have been made to optimize shRNA design and computational 
methods, RNAi technology exhibited important limitations. One such limitation is the 
incomplete loss of function due to RNAi, resulting in partial knockdown of the target 
gene and leading to false negative results during the analysis of the screens (Moore 
et al., 2010; Sigoillot and King, 2011). Another problem is the decreased sensitivity of 
the RNAi technology especially for genes with low expression levels, again leading to 
a significant false negative rate (Hart et al., 2014; Hong et al., 2014; Hu, 2004). 
Besides the false negatives arising due to technological limitations, false positives due 
to off-target effects are another major drawback of the RNAi system. Off-target effects 
refer to the observed phenotypes in shRNA screens, which arise from unintended 
interactions between the reagents and their accidental targets. Majority of these off-
target effects are dependent on nucleotide sequence of the shRNA and are due to the 
high tolerance for mismatches between the guide and the target mRNA (Birmingham 
et al., 2006; Boutros and Ahringer, 2008; Echeverri et al., 2006; Jackson et al., 2003). 
This problem is especially important during the analysis and interpretation of genome-
scale screens to identify essential genes as the unintended gene targets of the shRNA 
guides can be falsely labelled as an essential gene (Echeverri et al., 2006; Kaelin, 
2012). To overcome this limitation, the experiments can be designed so that every 
gene is targeted by multiple shRNAs to serve as a control with the expectation that 
they will result in the same phenotype (Echeverri et al., 2006). Because of these 
reasons, RNAi screens have to be designed and analyzed carefully, confirming results 
with orthogonal approaches. 
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1.3 Identification of essential genes with CRISPR-Cas9 
technology 
 
Compared to gene knockdown achievable with the RNAi system, gene 
knockout is a more reliable method to study gene function. With the advancement of 
genome editing technologies, Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR) system offers a useful tool to achieve gene knockdown and to offer 
new insights during functional genomics studies. 
 
1.3.1 CRISPR-Cas9 system in bacteria 
 
Clustered regularly interspaced short palindromic repeat sequences were first 
recognized in E.coli before the term CRISPR was initially put together (Ishino et al., 
1987). With advances in genomic sequencing, it was realized that these repeated 
elements, which appear in clusters, were present in members of distant phylogenic 
groups. However, unlike the regular tandem repeats in the genome, these sequences 
were shown to be separated by unique intervening sequences of uniform length called 
spacers (Mojica et al., 2000). As the genomes of several organisms were sequenced 
and compared with one another with computational methods, it was shown that these 
repeat and spacer elements were conserved within a species. More importantly, these 
regions were close to CRISPR associated genes (Cas) that showed homology in 
different species but their function was not clear (Jansen et al., 2002). Later it was 
realized that these elements were homologous to the genomic sequences of the 
phages (Mojica et al., 2005) and that CRISPR and the Cas proteins played a role in a 
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natural defense mechanism in bacteria as a way to evade viruses and bacteriophages 
(Barrangou et al., 2007). Immunity through CRISPR-Cas system in bacteria works by 
first integrating fragments of DNA, approximately 30 base pairs in length, from 
invading viruses into their bacterial genome at the leading edge of the CRISPR locus 
as spacers. In order for this acquisition process to occur, the host needs to select 
spacer precursors (proto-spacers)  by recognizing protospacer adjacent motif (PAM) 
in the viral DNA, the sequence of which shows variability depending on different 
CRISPR systems (Makarova et al., 2011). During the next stage of expression, a long 
primary transcript  (pre-cRNA) is transcribed with multiple spacers and then processed 
into short CRISPR RNAs (crRNAs) (Makarova et al., 2011; Wiedenheft et al., 2012). 
Each of these mature crRNAs contain a repeat and a spacer and forms a cascade 
with a Cas protein to form a crRNA-effector complex (Makarova et al., 2011). In the 
interference phase, the viral DNA/RNA is cleaved as the crRNA guides the crRNA-
effector complex to the complementary target sequences that match the spacer 
sequences, preventing the replication of invading viral genetic material (Makarova et 
al., 2011; Wiedenheft et al., 2012). 
 
Researchers who investigated Streptococcus pyogenes CRISPR  system 
found out that the crRNA interacted with a constant tracrRNA to form an RNA duplex 
(Deltcheva et al., 2011). Moreover this crRNA-tracrRNA complex in S.pyogenes was 
shown to bound to the Cas9 protein which is the endonuclease that cuts target DNA 
in type II CRISPR systems (Jinek et al., 2012). Strikingly, the authors also showed 
that this system can be used to cleave DNA in vitro with the engineering of a chimeric 
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20 nucleotide long single guide RNA (gRNA or sgRNA) which carries sequence 
complementarity to the target DNA (Jinek et al., 2012). Finally, later studies focused 
on the expression of the Cas9 and gRNA in eukaryotic cells to achieve programmable 
genome editing (Cong et al., 2013). 
 
1.3.2 Adaptation of CRISPR to mammalian cells 
 
Application of the bacterial CRISPR-Cas9 system for use in mammalian cells 
revolutionized the field of functional genomics, providing fast, systematic and high-
throughput genome editing.  Previous technologies such as homology directed repair 
(HDR) were inefficient with precise modification occurring in only 1 in 106- 109 cells 
(Capecchi, 1989). Soon it was discovered that DNA double strand breaks (DSBs) 
were repaired by either HDR or the error prone non-homologous end joining (NHEJ), 
which results in short insertions and deletions (Bibikova et al., 2002).  To facilitate 
DSB formation as more effective gene editing,  zinc finger nucleases (ZFNs) were 
developed using series of zinc finger domains from transcription factors in eukaryotes 
(Urnov et al., 2010). Similar to ZFNs, transcription-activator like effector nucleases 
(TALENs) consist of fusions of a cleavage domain with DNA binding domains from 
TALE proteins. They contain TALE arrays with 10-30 repeats which control DNA 
binding. Like ZNFs, TALENs can create targeted double stranded breaks to activate 
DNA damage response and enable genome editing (Gaj et al., 2013; Gupta and 
Musunuru, 2014). Although these nucleases can be programmed to achieve precise 
genome editing in mammalian cells, both technologies are too laborious and they 
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require significant optimization steps, making them unsuitable for large scale and 
routine applications. 
 
Despite the difficulties of the ZFNs and TALENs, CRISPR-Cas9 technology 
offers a more simplistic and highly efficient genome editing capabilities in multiple 
organisms. The genome editing function of CRISPR-Cas9 system from bacteria was 
recapitulated in mammalian cells by expressing sgRNAs with optimized Cas9 with the 
addition of nuclear localization signals. 20 base pair sgRNAs are designed to target a 
specific site in the genome that is immediately 5’ of the PAM sequence, which is 
“NGG”, for it to be recognized by S. pyogenes Cas9. After being guided by the sgRNA 
to the target sequence, Cas9 cleaves the DNA, inducing a double strand break which 
is repaired by the NHEJ or the HDR pathway if a donor DNA template is provided 
(Cong et al., 2013; Jinek et al., 2013; Mali et al., 2013). The simplicity of the method 
also enabled the creation of large sgRNA libraries and multiplexing by expressing 
multiple sgRNAs on a single vector to study genetic interactions (Cong et al., 2013; 
Mali et al., 2013). 
 
1.3.3 Genetic screens using CRISPR-Cas9 technology 
 
Adaptation of the bacterial CRISPR-Cas9 system to mammalian cells enabled 
genome-scale approaches to define human essential genes. Prior to this technology, 
RNAi was the best performing method to perform loss of function screens to study 
gene essentiality. However, as discussed previously, due to incomplete loss of 
function, decreased sensitivity for genes with low expression levels and confounding 
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off-target effects, RNAi lost its popularity as the potential therapeutic targets identified 
through these screens could not be validated in other studies. Compared to the RNAi 
technology, CRISPR-Cas9 system induces a complete loss of function in the target 
genes by creating a double strand break in the DNA, which is repaired by NHEJ repair 
because a homology template is not provided. This error-prone repair mechanism 
creates indels which lead to frameshift mutations or a premature stop codon that 
results in a truncating mutation and to loss of function.  Using this efficient genome 
editing tool, several groups designed pooled genome-wide CRISPR-Cas9 knockout 
libraries to perform loss of function screens (Koike-Yusa et al., 2014; Shalem et al., 
2014; Wang et al., 2014). In these screens, Cas9 is delivered into cells either on the 
same lentiviral vector as the chimeric sgRNA, which is expressed through a U6 RNA 
polymerase III promoter, in a one-component system (Shalem et al., 2014) or on a 
separate vector (Koike-Yusa et al., 2014; Wang et al., 2014) in a dual component 
system.  
 
In the genome-scale CRISPR-Cas9 knockout (GECKO) library study, ~18,000 
genes were targeted with 64,751 sgRNAs to identify essential genes in a melanoma 
cell line and the authors observed that guides targeting expected essential genes were 
significantly depleted (Shalem et al., 2014). The same study also performed a positive 
selection screen to investigate genes essential for developing resistance to 
vemurafenib and identified NF1 and MED12 genes as hits. Another study screened 
two leukemia cell lines with a library targeting ~7,000 genes with 10 sgRNAs per gene 
and observed that genes that are involved in fundamental biological processes of the 
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cell showed the greatest depletion (Wang et al., 2014). Moreover, this study 
investigated features that determine sgRNA efficiencies and built an algorithm to 
predict strong sgRNAs. The other genome-scale library used ~88,000 guides to target 
~19,000 mouse genes and identified several genes that regulate mechanisms of 
resistance to Clostridium alpha-toxin or 6-thioguanine in mouse embryonic stem cells 
(Koike-Yusa et al., 2014). 
 
These first-generation proof of concept genome-scale CRISPR-Cas9 knockout 
screens provided significant insights that were essential for the development of 
efficient next generation libraries. These libraries were used in negative selection 
screens to expand the sets of essential genes in human cancer cells (Hart et al., 2015; 
Wang et al., 2015). The Hart et al. study used the high complexity Toronto Knockout 
version 1 (TKOv1) library targeting 17,661 protein coding genes to find essential 
genes in a diverse set of cancer cell lines arising from different lineages (Hart et al., 
2015). With negative selection screens using TKOv1 library in 5 cell lines, the authors 
identified ~2000 high confidence fitness genes in each cell line and strikingly this 
finding revealed that CRISPR technology can identify 4-5 times as many hits as RNAi 
screens with the same false discovery rate (FDR) in the same HCT116 cell line (Hart 
et al., 2015). An independent study by Wang et al used an optimized sgRNA library in 
chronic myelogenous leukemia and lymphoma cell lines and also identified ~2000 
essential genes in a cell line (Wang et al., 2015). Another study in 5 acute myeloid 
leukemia (AML) cell lines used a ~90,000 sgRNA library to target ~18,000 genes and 
identified approximately 2,000 essential genes at 20% FDR (Tzelepis et al., 2016).  
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All of these aforementioned studies demonstrated that CRISPR-Cas9 
technology offers a superior sensitivity in detecting essential genes, accomplishing 
genetic knockout by directly targeting DNA compared to RNAi which targets mRNA 
transcripts to trigger reduced gene function. However, CRISPR technology also 
showed some important limitations. The first limitation was due to the fact that the 
sgRNAs for CRISPR-Cas9 libraries were designed to target the 5’ coding exon of the 
target gene. This sometimes results in frameshift or in-frame mutations which can 
retain their functions and thus can hinder the knockout phenotype (Shi et al., 2015). 
Alternatively, sometimes exons other than those located at the most N-terminal region 
can contain an alternative transcription initiation site which might be sufficient for gene 
expression, creating a lack of dropout phenotype (Munoz et al., 2016). Fortunately this 
limitation can be overcome by targeting exons containing conserved functional protein 
domains which creates a higher ratio of  null mutations and increased negative 
selection (Munoz et al., 2016; Shi et al., 2015). A similar genome-wide CRISPR-Cas9 
loss of function also showed that targeting conserved protein coding regions of a gene 
with sgRNAs causes more significant depletion than targeting the same gene in  a 
less conserved region (Bertomeu et al., 2018). 
 
Another important confounding factor during the analysis and interpretation of 
genome-wide CRISPR-Cas9 knockout screens are the false positive knockout 
phenotypes that are due to gene-independent effects in copy number amplified 
regions.  This phenomenon is observed because multiple double stranded breaks are 
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induced when sgRNAs target amplified loci, triggering DNA damage response, 
resulting in increased phosphorylation of H2AX, subsequent cell cycle arrest and 
apoptosis (Aguirre et al., 2016; Munoz et al., 2016; Wang et al., 2015). It is important 
to correct for these gene independent effects especially during identification of 
essential genes since the genes that reside in copy number amplified regions will 
exhibit strong loss of function phenotypes, being falsely labeled as essential genes. 
To correct for these potential false positives from genome-scale CRISPR-Cas9 
knockout screens, different computational algorithms such as CERES (Meyers et al., 
2017) and CRISPRcleanR (Iorio et al., 2018) have been developed and are widely 
used. 
 
1.3.4 Large scale efforts of CRISPR-Cas9 screening to identify 
genomic vulnerabilities in cancer cells 
 
Recently, there have been massive efforts by the Broad Institute of MIT and 
Harvard and the Wellcome Sanger Institute under the collective Cancer Dependency 
Map project (DepMap Consortium), which aims to identify cancer specific weaknesses 
through genetic perturbations across hundreds of cancer cell lines from multiple 
cancer types (Behan et al., 2019; Meyers et al., 2017; Tsherniak et al., 2017). These 
datasets include experimental data from CRISPR-Cas9 genome-scale loss of function 
screens as well as mutation, gene expression and copy number data from hundreds 
of human cancer cell lines. New data from additional cell lines are released quarterly 
in the DepMap portal under Project Achilles, which currently has data from 808 cell 
lines screened with the Avana library in the 2020Q4 release (Broad DepMap, 2020a). 
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Similarly, the Sanger Institute has released data under the Project Score which 
comprises 324 whole-genome CRISPR-Cas9 screens to identify cancer specific 
dependencies (Behan et al., 2019). For the first time, these publicly available datasets 
enabled researchers to conduct systematic analyses from hundreds of cell lines to 
identify genomic dependencies that can be targeted therapeutically. After the release 
of these massive datasets, computational tools were also developed specifically to 
correct for the false positive essential genes that arise due to gene-independent 
effects in copy number amplified regions (Iorio et al., 2018; Meyers et al., 2017). An 
extensive analysis of the Sanger dataset with more than 300 cell lines revealed 
dependence on known oncogenes, such as cellular reliance on BRAF in BRAF 
mutated cells. One novel finding from this study was the Werner  syndrome ATP- 
dependent helicase (WRN) as a synthetic lethal therapeutic target for tumors that 
show microsatellite instability (MSI).  
 
 
1.3.5 Genetic interactions and synthetic lethality 
 
Genome-scale CRISPR-Cas9 knockout screens focus on evaluating the 
functional impact of individual gene perturbations in order to identify cellular 
dependencies. As described in the previous sections, these studies have identified 
about 10% of the genes in the human genome as essential, indicating the significance 
of functional buffering.  Hence, it is important to highlight the significance of genetic 
interactions, which explains the presence of context-dependent essential genes, the 
loss of which creates a fitness defect in only a specific genetic background. 
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A genetic interaction between two genes is defined as an unexpected 
phenotype that arises from mutations of both genes (Costanzo et al., 2010; Mani et 
al., 2008; Tong, 2004). If the mutations in two genes results in an increased 
proliferation phenotype, this gene pair is considered to have a positive genetic 
interaction. Conversely, if the mutations in two genes results in reduced fitness 
compared to the expected phenotype, these two genes show a negative genetic 
interaction. The severity of the negative genetic interactions can range from being mild 
as in synthetic sick interactions to the most severe form which is synthetic lethality. 
 
The concept of synthetic lethality is particularly significant in the context of 
cancer since exploiting cancer specific vulnerabilities to target cancer cells while 
leaving the normal tissue unharmed is the dream of cancer therapy. Synthetic lethality 
can be seen as a type of context-dependent gene essentiality where the inhibition of 
a  particular gene kills only the cancer cells which have a loss of function of its 
synthetic lethal pair, without effecting normal cells that do not have the same loss of 
function phenotype. It can also be considered as an essential functional interaction 
between two nonessential genes. Therefore, synthetic lethal interactions are 
considered as promising therapeutic targets in personalized medicine due to 
conceivably reduced side effects as well as the potential to indirectly target previously 
non-targetable genes. Since many tumor suppressors and oncogenes cannot be 
targeted easily by pharmacological agents, there is an urgent need to identify genes 




Despite its enormous promise, not many clinically relevant synthetic lethal 
interactions have been successfully translated for use in the clinics. The most well-
known example is the PARP inhibitor olaparib which is the first clinically approved 
drug to exploit synthetic lethality between the BRCA1/2 and PARP genes (Lord and 
Ashworth, 2017, 2008). Since cancer cells that have homozygous BRCA1/2 loss of 
function mutations become dependent on PARP activity, the treatment of these cells 
with a PARP inhibitor results in cellular death (Bryant et al., 2005). This phenomenon 
is observed because a complete loss of function of BRCA1/2 renders the cell without 
a functioning homologous recombination DNA repair mechanism, which is responsible 
for an error free double strand break repair. PARP encodes for a nuclear protein that 
plays a role in base excision repair, which is a type of DNA single strand break repair. 
PARP inhibitors block the base excision repair mechanism in the BRCA1/2 mutated 
homologous recombination deficient cells. This results in a nonfunctioning DNA repair 
mechanism in the cell leading to accumulation of mutations, genomic instability and 
cell death (Lord and Ashworth, 2017). PARP inhibitors have been used for BRCA1/2 
mutated breast ovarian cancer and they have shown to be most effective in platinum 
sensitive patients (Konecny and Kristeleit, 2016). Although BRCA deficiency occurs 
in only a fraction of cancer patients, the idea of synthetic lethality has inspired 
researchers to build genetic interaction networks to discover novel synthetic lethal 
interactions that can be exploited therapeutically. 
 
1.4 Overview of dissertation research 
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In cancer therapy, killing cancer cells selectively without harming surrounding 
healthy tissue remains a major challenge. The toxicity of conventional treatment 
methods to the normal cells stresses the need for new strategies that can identify and 
address the weaknesses specific to cancer cells. Genetic knockout screens identify 
essential genes and can be performed on a genome scale in mammalian cells using 
CRISPR-Cas9 technology. While it is widely accepted in the field that CRISPR 
screening is both more specific and more sensitive than previously established 
methods, the limitations of this technology have not been systematically investigated. 
Moreover, current methods to precisely define essential genes depend on arbitrarily 
defined thresholds, which results in  an inaccurate definition of core, context and non-
essential genes across hundreds of different backgrounds.   
 
The overall objective of this dissertation is to use pooled genome-wide 
CRISPR-Cas9 loss of function screens to advance our understanding of human gene 
essentiality and identify context-dependent essential genes and vulnerabilities in 
different cancer types. Chapter 2 will focus on the systematic analysis of CRISPR 
screens from hundreds of cell lines to demonstrate the biases in these screens. The 
analyses will include development of a computational approach that models the actual 
expected number of essential genes in an average pooled genome-wide CRISPR-
Cas9 loss of function screen, estimation of the FDR and false negative rate (FNR) in 
a “typical” CRISPR screen using data from the Broad and Sanger screens. These 
analyses will establish a ground truth for a typical CRISPR screen. Moreover, another 
modeling approach that defines high-confidence core and context essential genes in 
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these screens will be discussed. Chapter 3 will focus on the false negative (FN) 
problem in these screens and will address this challenge using another computational 
method. Therefore, these two chapters will demonstrate a detailed analysis of these 
genome-wide CRISPR screens, focusing on what we can learn from these screens. 
On the other hand, Chapter 4 will focus on the blind-spots in monogenic knockout 
screens, highlighting the significance and implications of the type of information that 
we are missing from the previous analyses. Collectively, these chapters will improve 
our understanding of human gene essentiality, taking us one step further from the 
foundational concepts described in the previous sections. The analyses will reveal 
significant biases and blind-spots in the analysis of CRISPR-based functional 
genomics approaches, and offer new opportunities for the discovery of novel 















Chapter 2:  Identification of high-confidence 
essential genes and the biases in CRISPR-Cas9 
knockout screens 
The majority of analyses found in this chapter are adapted from the following 
preprint manuscript using an updated version of the Avana data release (2020Q2):  
Dede, M., Kim, E., & Hart, T. (2020). Biases and Blind-Spots in Genome-Wide 
CRISPR Knockout Screens. BioRxiv. 
The copyright holder for this preprint is the author/funder, who has granted 
bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-




With the adaptation of bacterial CRISPR-Cas9 system to mammalian cells and 
developments in genome-wide pooled CRISPR-Cas9 knockout screening, studies 
have shown that CRISPR technology enables greater sensitivity and specificity 
compared to previous gold-standard technologies in detecting essential genes. 
Although these developments have been instrumental for the identification of 
targetable cancer specific vulnerabilities, the assumption that CRISPR screens are 
saturating has been largely untested. In this chapter, I describe my work on an 
integrated analysis of genome-wide screen data in cancer cell lines generated by the 
Cancer Dependency Map from the Broad Institute and Project Score by the Sanger 
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Institute, to estimate the expected number of essential genes in an average genome-
wide CRISPR-Cas9 screen, establish a false positive (FP) and a false negative rate 
(FNR). I will demonstrate different biases that we observe and will also define a set of 
high-confidence common and context essential genes across these datasets to define 




The search for essential genes - genes whose loss of function results in a 
severe fitness defect - has been of outstanding interest to the scientific community. 
Prior to advanced genomic technologies, the assumption was that the majority of 
genes were essential for life (Horowitz and Leupold, 1951). This idea was dismissed 
by several studies that utilized saturating random mutagenesis to show that in C. 
elegans and S. cerevisiae, 12-15% of the genome was estimated to be essential 
(Brenner, 1974; Goebl and Petes, 1986). These studies were limited by the methods 
at the time and the lack of the availability of complete genome sequences.  
 
After improvements in shotgun sequencing, initial studies to define essential 
genes in bacteria were driven by the desire to identify antimicrobial targets with the 
first minimal genome screen performed in Mycoplasma genitalium (Hutchison et al., 
1999).Later studies revealed the essential genes in other bacteria including M. 
tuberculosis, P. aeruginosa and H. influenza (Akerley et al., 2002; Jacobs et al., 2003; 
Sassetti et al., 2001). 
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With the advances in genome technologies that enabled sequencing of 
eukaryotic organisms, systematic gene knockout studies were performed in S. 
cerevisiae, identifying essential genes by deletion of open reading frames in the yeast 
genome This method identified that 17% of yeast genes were essential for growth in 
rich medium (Winzeler et al., 1999).  However, a later study showed that a binary 
classification of genes into essential and non-essential was misleading due to the 
context dependent nature of gene essentiality and that 97% of yeast genes showed 
some growth phenotype under different environmental conditions (Hillenmeyer et al., 
2008).  
 
Developments in RNA interference (RNAi) technology provided valuable 
insight into detection of fitness genes. Generation of genome scale RNAi libraries to 
conduct genome-wide RNAi screens facilitated the study of essential genes in multiple 
organisms (Dietzl et al., 2007; Kamath et al., 2003; Meister and Tuschl, 2004; Moffat 
and Sabatini, 2006). In these RNAi screens, 30% of the genome was shown to be 
essential in D.melanogaster cell lines, (Dietzl et al., 2007), compared to only 8.5% of 
the C.elegans genome in whole worms (Kamath et al., 2003).  
 
Identifying essential genes in human cancer cells is of special interest in 
oncology since the cancer-specific essential genes represent genomic vulnerabilities 
that can potentially be targeted with novel therapeutic agents. An initial study showed 
that some colorectal cell lines were dependent on a specific KRAS mutation for growth 
and survival (Shirasawa et al., 1993).  Later this idea was explored under the term 
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“oncogene addiction” that describes the dependency of cancer cells on specific 
oncogenes for sustained growth and proliferation (Weinstein and Joe, 2008). To 
identify these oncogenes, RNAi screens were performed on small arrays of cancer 
cells to search for essential genes (Moffat et al., 2006; Schlabach et al., 2008; Silva 
et al., 2008). Subsequent larger-scale efforts such as the Project Achilles of the Broad 
Institute focused on context specific gene essentiality across 216 human cancer cell 
lines screened with an shRNA library (Cowley et al., 2014).  Similarly, another 
relatively big scale study in 72 cell lines (Marcotte et al., 2012) produced consistent 
results with the previous studies, indicating confidence in the methodology. Even 
though significant efforts have been made to optimize reagent design and analytical 
methods, RNAi technology was shown to have significant limitations such as 
incomplete loss of function due to RNAi, decreased sensitivity for genes with low 
expression levels (false negatives) and confounding off-target effects (false positives) 
(Boutros and Ahringer, 2008; Echeverri et al., 2006; Hart et al., 2014). 
 
More recently, adaptation of the bacterial CRISPR-Cas9 system to mammalian 
cells enabled genome-scale approaches to define human essential genes. Studies 
using this technology revealed that mammalian cells have more essential genes than 
RNAi screens were able to detect and that, at the same false discovery rate, CRISPR 
screens generated 3-4 times more essential genes (Hart et al., 2014). Moreover, 
multiple groups revealed lists of ~2000 highly concordant human essential genes, and 
comparison of CRISPR technology to orthogonal techniques such as random insertion 
of gene traps also showed consistent results  (Blomen et al., 2015a; Hart et al., 2015; 
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Wang et al., 2015). These findings were initially thought to indicate that the CRISPR-
Cas9 screens are saturating and that a well-designed screen can detect a cell's full 
complement of essential genes. However, it is still poorly understood how the possible 
systematic biases in CRISPR screens affect our understanding of human gene 
essentiality. In the absence of a ground truth, the actual true positive, false positive 
and false negative rates are in an average genome-wide CRISPR-Cas9 knockout 
screen are still unknown. In this chapter, we will conduct a systematic analysis of 
genome-wide CRISPR-Cas9 knockout screens to model how many essential genes 
we expect to find in an average CRISPR screen, estimate the false discovery and 
false negative rates and reveal the biases we observe in our analyses. 
 
2.3 Results 
2.3.1 Overview of the Avana data 
 
In order to perform a systematic analysis of the screens, we obtained the raw 
read counts of pooled genome-wide CRISPR-Cas9 loss of function screens performed 
in 769 genetically heterogeneous cell lines from the 2020Q2 release of the publicly 
available Avana data (Broad DepMap, 2020b; Meyers et al., 2017). We processed the 
data by applying our computational pipeline as described in detail in the methods 
section in 2.5. Briefly, we utilized the CRISPRcleanR algorithm (Iorio et al., 2018) to 
correct for gene-independent copy number artifacts and calculated the log2FC for 
each gene in every screen. Next, we evaluated gene essentiality by assigning an 
essentiality score, Bayes Factor (BF) to each gene in every screen using a recently 
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updated version of our BAGEL algorithm (Kim and Hart, 2021). After applying quality 
control metrics by evaluating the precision recall curves, (Figure 2.1A) and calculating 
F-measures, we constructed a final dataset of 659 cell lines which satisfied the F-
measure criteria of 0.8 and above (Figure 2.1B). 
 
 
Figure 2.1. Avana data quality control metrics. A) Precision-recall curves for a high quality 
versus low quality screen. The red dots indicate where the Bayes Factor equals 5. B) The 
histogram of F-measures show that the majority of Avana screens are high-performing, with 
86% of the screens displaying F-measures greater than or equal to 0.80 as indicated by the 
red dashed line. 
 
These 659 cell lines are derived from 25 different tissue types, with varying 
representation (Figure 2.2). 
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Figure 2.2. Avana cell lines constitute 25 tissue types in 2020Q2 release. Red bars indicate 
tissues that are represented by more than or equal to 16 cell lines and blue bars represent 
tissue types with less than 16 cell lines. 
 
2.3.2 Synthetic genome modeling of essential genes in 659 cell 
lines in the Avana data 
 
To estimate the total number of essential genes in a cell, we employed a 
method based on the cumulative essentiality observations across all screens in the 
Avana data. Our approach is based on the expectation that, for a sufficient number of 
identical screens without any false positives, a plot of the cumulative number of 
essential genes would flatten to a slope of zero when all of the essential genes in the 
population are identified. In contrast, in a population of screens with either cellular 
heterogeneity or some degree of false discovery rate (most likely both), the slope of 
the cumulative essential genes plot would remain positive, reflecting the continuous 
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accumulation of false positives as well as cell line specific essential genes in otherwise 
saturated screens. This principle was previously demonstrated to estimate the total 
population of essential genes detectable with RNAi technology (Hart et al., 2014). 
 
We applied this logic to the Avana dataset and plotted the cumulative essential 
genes across sets of 20 cell lines that are randomly selected without replacement from 
all Avana screens (Figure 2.3). The sampling process was repeated 100 times to 




Figure 2.3. Avana screens have a cumulative essentials plot with a positive slope. The blue 
circles indicate the number of cumulative essential genes in each screen and the green 
triangles indicate the number of newly discovered essential gene hits in each consecutive 
screen. The error bars indicate the standard deviation of the number of cumulative essential 
genes and the newly discovered essentials in 100 iterations. The black line indicates the 
saturation point at 8 screens. 
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To define gene essentiality, a strict threshold of BF>10 was used for every 
gene in each screen since this threshold represents a posterior probability of gene 










Figure 2.4. The relationship between the posterior probability of essentiality and Bayes 
Factors. BF of 10 (black dashed line) represents a posterior probability of essentiality of 99% 
indicated by the red dashed line. 
 
Using this BF 10 threshold yielded a cumulative essentials curve that 
converged to a positive slope, which was consistent with previous observations in the 
shRNA screens (Figure 2.3). This plot represents significant trends in the data: first, 
there exists a fixed population of essential genes across all screens. The number of 
cumulative essentials increase rapidly at first and then the curve continues with a 
positive slope as more screens are added. Second, the screening methodology 
cannot confidently capture all the essential genes in a single experiment. An average 
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screen renders between 1250-1300 essential gene hits but the saturation point 
indicated by the black line in Figure 2.3 indicates ~2500 hits. Therefore, it is obvious 
that all essential genes cannot be captured in a single experiment and each screen 
carries some unknown false negative rate (FNR). Multiple screens are needed before 
all essential genes in the population can be identified. Third, after the saturation point 
is reached, additional screens continue to accumulate a combination of false positives 
as well as context-specific essential genes that were either not detectable or not 
present in the prior set of screens, and that the rate at which these genes are observed 
offers some estimate of the false discovery rate of each screen. 
 
To model these factors, we carried out repeated screens in silico and compared 
synthetic cumulative essential curves to those derived from the data. Starting with a 
genome of N=18,111 genes – the number of genes tested in the Avana library – we 
arbitrarily defined n essential genes, leaving N-n nonessential. We further defined an 
arbitrary screen false discovery rate between 1-15%. Then we repeatedly sampled 
this genome with a screen that randomly drew 1,287 hits – the mean number of hits 
at BF>10 across all Avana screens -- from the essential and nonessential populations 
based on the defined FDR (e.g. at 10% FDR, 129 nonessentials and 1,158 essentials 
were randomly selected; see Figure 2.5A). Finally, we determined the cumulative hits 
across eight iterations, estimating that eight samples was a good estimate of screen 
saturation in the data (sFigure 2.3) and judging that it was more important to fit the 
model to our observations in this region than in the saturated region. We calculated 
the root-mean-squared deviation from the mean cumulative essentials curve 
 38 
determined from the Avana data and plotted RMSD vs. the two parameters of the 
model observing that the best fit occurred with n=1,600 essential genes and 
FDR=9.5% (Figure 2.5B,C). Notably, a region of good fits, with RMSD < 2xRMSDmin, 
occurs between n=1,500-1,800 essential genes and a corresponding decrease in per-
screen FDR from 9.5% to ~6.5% (Figure 2.5D). 
 




Considering the range of different tissue types that the screened cell lines are 
derived from, it is clear that some of the context-specific essential genes will be 
included in the false positives in our synthetic genome approach. In order to minimize 
the effect of these tissue-specific essential genes, we repeated the analysis using cell 
lines from only one tissue type, filtering for 18 tissues that are represented by at least 
16 high performing screens (Figure 2.2). Each tissue type yielded similar cumulative 
essential curve (Figure S2.1) as shown here for the colorectal cancer cell lines in the 
Avana data (Figure 2.6). We repeated this modeling approach in each tissue type and 





Figure 2.5. Synthetic genome modeling estimates 1600 essential genes in an average 
screen and 9.5% FDR. A) Diagram overview of the synthetic genome modeling of essential 
genes. From a synthetic genome of 18,111 genes, 1287 hits were randomly sampled from 
the essential (n) and non-essential gene (NEG) populations based on the defined false 
discovery rate (FDR) in the simulation. The resulting cumulative essential hits across 8 
iterations were plotted and compared to the mean cumulative essentials curve from the 
Avana data. B) The synthetic genome modeling reveals that the best fitting model with 
n=1600 genes and 9.5% FDR indicated by the white box. C) Plot showing the model with 
the best fit (in blue) to the Avana data 2020Q2 release (red). D) Box-plot showing the 
distribution of the RMSD values for each simulation. The red dashed line indicates twice the 




Next, we compared the best-fit number of essential genes from the synthetic 
genome model in each tissue type to the mean number of essential gene hits observed 
in that same tissue type and calculated an average false negative rate across each 
tissue. Across all tissue types we examined, we determined the mean FNR to be 







Figure 2.6. Synthetic genome model identifies the number of essential genes in each tissue 
type. A) Synthetic genome model estimates 1600 essential genes and 10% FDR among 
colorectal cancer cell lines in the Avana data (white rectangle). The red circle represents 
the region of good-fit models with less than twice the minimum RMSE values. B) Plot 






Figure 2.7. False negative rates in different tissue types in the Avana data. Average screen 
FNR was determined by comparing the number of essential genes from the best fit model in 
each tissue type to the mean number of observed essentials in each tissue type. The red 
dashed line indicates a mean FNR of 21.2% across all tissue types tested. 
 
2.3.3 Saturation modeling to differentiate essential genes and false 
positives 
 
While our synthetic genome approach described in the previous section gave 
us an estimate of the expected total number of essential genes and the FDR in an 
average screen, it does it does not provide any way to differentiate true hits from false 
positives. To address this issue, we utilized an alternative view of the saturating 
behavior of CRISPR screens, similar to the methodology described for shRNA 
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screens (Hart et al., 2014). Based on our judgment that screening in virtually all 
lineages achieved saturation after roughly eight cell lines had been effectively 
screened, we again selected the lineages with at least twice this number of cell lines 
indicated in Figure 2.2. From each of these tissue types, we randomly selected eight 
screens (“initial screens”) without replacement, identified the cumulative number of 
essential genes (defined by BF>10) and determined the number of cell lines in which 
each gene was classified as essential. We then randomly selected an additional eight 
screens (“subsequent screens”), again without replacement, and determined the 
number of cell lines in which each gene was classified as new hits – that is, BF>10 
but not a hit in any of the initial eight screens (Figure 2.8A). We assumed that all of 
these new hits were false positives, and that the histogram of observations of these 
false positives estimates the frequency of false positives in the initial screens. It is 
almost certainly not the case that all of these are actually false positives, given the 
known presence of tumor subtypes within each tissue/lineage, the high likelihood of 
subtype-specific essential genes, and the probability that any given subtype escaped 
being selected in the initial eight screens. However, this assumption is useful for 
modeling purposes, as it provides an estimate of the upper bound of the false 
discovery rate using this saturation modeling approach. We repeated this process 100 




Figure 2.8. Saturation modeling approach to identify high confidence essential genes. A) The 
number of cumulative essential genes and the newly discovered hits in each consecutive 
screen among colorectal cancer cell lines in the Avana data. B) Histogram showing the 
distribution of the number of essential genes and the number of cell lines in which each gene 
was classified as essential in colorectal cancer cell lines. Blue bars represent the distribution 
of true positives (TPs) and the orange bars represent the frequency of false positives (FPs). 
 
The histogram in Figure 2.8B indicates that the putative false positives (orange 
bars) show the expected distribution that most are detected in only a single screen. 
We used the distribution of the true and false positives to estimate both bin-wise and 
cumulative false discovery rates (Table S1. Bin-wise FDRs for each tissue type in the 
Avana data using saturation modeling approach.) by comparing the ratio of putative false 
positives to the total number of hits in each bin. We observed that the bin-wise FDR 
falls to less than 3% for genes that are observed in 3 or more out of 8 screens. 
Therefore, we determined that genes observed in 3 or more of 8 randomly selected 
screens represent the high-confidence set of essential genes in a given tissue type 
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and this set includes both genes that are frequently false negatives as well as those 
that are subtype-specific within a lineage. 
 
2.3.4 False negatives and subtype specific genes 
 
A closer examination of the U-shaped histogram in Figure 2.8B reveals 
significant implications. Genes that are observed as essential in the intermediate 
number of screens (3 to 6 out of 8) are either false positives that are repeatedly 
observed, false negatives that are repeatedly missed, or cancer subtype-specific 
genes that are only essential in some cell lines, violating our modeling assumption 
that the cell lines are identical (in reality, some combination of these three possibilities 
is more likely). We demonstrate from the hit frequency of the subsequent screens (in 
orange) that these genes are very unlikely to be false positives. In this section, we 
attempt to differentiate between false negatives and context-essential genes. 
 
First, we examined the mean mRNA expression levels of genes in each bin in 
the corresponding cell lines that they were detected as essential. We observed a clear 
trend in which more frequently observed essential genes show higher gene 
expression (Figure 2.9A). This is in contrast to genes that are observed as hits in only 
one out of eight screens, highly enriched for false positives which show markedly 
lower expression. Moreover, putative false positives from the subsequent set of 8 




Figure 2.9. Expression bias exists in CRISPR-Cas9 screens. A) For the true positives in 
colorectal cancer cell lines, the mean mRNA expression (log2(TPM)) of the genes in each bin 
shows higher expression where more frequently observed essential genes show higher levels 
of expression. B) The mean mRNA expression (log2(TPM)) of the genes in each bin for the 
false positive gene distribution. C) Violin plot showing the distribution of the essentiality scores 





Next, we questioned the essentiality profiles of genes in the screens where the 
gene was not observed as an essential gene. The violin plot in Figure 2.9C measures 
whether a gene that is essential (BF>10) in, for example, 5 screens is truly non-
essential in the remaining 3 screens with very negative essentiality scores (BF <-10) 
or whether it falls in the intermediate range near BF=0. Shows that the more frequently 
a gene is classified as essential in the initial screens, the higher its average BF in 
screens where it is not essential. This observation is strongly consistent with false 
negatives rather than context-dependent essential genes. 
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Figure 2.10. Differentiating cancer subtype-specific essential genes from false negatives in 
CRISPR-Cas9 screens. Top left panel: Functional enrichment of genes in colorectal cancer 
cell lines based on their mean number of hits observations out of 8 screens in 100 iterations. 
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Top right panel: mean mRNA expression (log2(TPM)) in colorectal cancer cell lines of the 
genes involved in the enriched pathways shown in the left panel. Bottom panel: Hierarchical 
clustering of the colorectal cancer cell lines based on the essentiality scores of the genes 
involved in pathways shown in left and middle panels. 
 
In order to differentiate between false negatives and cancer subtype-specific 
essential genes, we measured functional enrichment of gene annotations as a 
function of mean essentiality stringency thresholds. We plotted the P-value of 
annotation enrichment for several processes that demonstrate the major trends we 
observed in the data. Genes associated with the cytoplasmic ribosome, which should 
be universally essential across all cell lines, show peak enrichment at high hit 
frequency (hits in n>=7 of 8 screens in 100 random samples from colorectal cancer 
cell lines; Figure 2.10 top left panel). Consistent with the expression bias shown in 
Figure 2.9A, these genes are very highly expressed in the cell (Figure 2.10 top right 
panel). Similarly, genes encoding proteasome subunits which are essential for 
proliferation of all cells, show near-maximal enrichment at high frequency of 
observation (n>6.5, Figure 2.10 top left panel), and are relatively highly expressed 
(Figure 2.10 top right panel). In contrast, genes involved in mRNA export from the 
nucleus and RNA degradation—which should also, in principle, be universally 
essential—show consistent increase in enrichment as frequency of observation is 
relaxed (Figure 2.10 top left panel), and these genes are expressed at intermediate 
levels (Figure 2.10 top right panel). Collectively, these trends are consistent with a 
significant false negative rate among moderately expressed genes that should 
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otherwise exhibit consistent fitness defects across cell lines. Moreover, this trend is 
easily differentiated from context-specific modular functions: genes related to 
mitochondrial translation and oxidative phosphorylation only show enrichment at low 
frequency of observation (Figure 2.10 top left panel), despite their robust gene 
expression (Figure 2.10 top right panel). A summary of gene essentiality scores and 
trends in the colorectal cancer cell lines displayed here is shown in Figure 2.10 bottom 
panel, with context-dependent oxidative phosphorylation genes driving the 
hierarchical clustering of cell lines. A more extensive demonstration and discussion of 
the false negative genes will be discussed in the following chapter of this dissertation.  
 
2.3.5 High-confidence context-essential genes and a newly defined 
set of core essential genes 
 
In section 2.3.3 we had mentioned that genes observed in 3 or more out of 8 
screens represent the high-confidence set of essential genes in a given tissue type. 
Comparing all tissue types we evaluated in the Avana data, we identified 992 genes 
that are essential at that frequency in all 18 tissue types we evaluated (Figure 2.11). 
Additionally, we observed that each tissue type carries an additional 300-600 context 
specific essential genes (Figure 2.11 inset), which make up the petals of the daisy. 
Interestingly, these additional context-essentials are also widely, but not universally, 
shared across backgrounds: each lineage has only 3 (central nervous system) to 41 
(hematopoietic and lymphoid) genes which are uniquely essential in that lineage. We 
found many known gene-tissue relationships in this set of unique context essentials. 
For example, the SOX10 transcription factor was found to be essential in only skin 
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cells where it plays a major role in the production and function of melanocytes  (Harris 
et al., 2010; Nonaka et al., 2008). CTNNB1 and TCF7L2 are essential only in 
colorectal cancer cell lines, where activation of the Wnt pathway results in 
accumulation of B-catenin that interacts with and acts as a coactivator for TCF7L2 
that in turn activates downstream genes responsible for colorectal cancer cell survival 
as well as resistance to chemo-radiotherapy (Albuquerque and Pebre Pereira, 2018; 
Emons et al., 2017; Murphy et al., 2016). ER+ breast cancer cell lines specifically 
depend on transcription factors FOXA1 and GATA3, which are overexpressed in ER+ 
breast carcinomas (Albergaria et al., 2009; Davis et al., 2016). E2F1, which was 
uniquely essential in only pancreatic cancer cells, has been previously shown to 
regulate both pancreatic B-cell development and cancer growth by increasing the 
expression of PDK1 and PDK3 which results in increased aerobic glycolysis and 
growth in pancreatic cancers (Denechaud et al., 2017; Kim and Rane, 2011; Wang et 




Figure 2.11. High confidence essential genes show significant overlap between tissue types. 
Top: The new daisy model of gene essentiality. In this model, genes essential in a certain 
tissue type is represented by the petals of the daisy indicating their numbers for each tissue. 
The petals overlap to varying degrees, but everything shares the common set of essential 
genes (N=992). Bottom: Upset plot showing the overlap of high-confidence essential genes 
in different tissue types. 
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Nevertheless, we demonstrate that genes uniquely essential in a particular 
context are very rare, while hundreds of genes are shared across some but not all 




2.3.6  Comparing common essentials to previous gold standard 
core essential genes 
 
The common essentials defined in this study include genes that are identified 
as hits in every tissue type at a frequency of at least 3/8 screens. Therefore, they 
should, in principle, define a superset of previously defined gold standard sets of core 
essential genes. We compared our set of 992 common essential genes as depicted 
as the core of the daisy in  Figure 2.11 to the Core Essential Genes v2 (CoreV2) that 
we had previously defined as a gold standard training set for our BAGEL algorithm 
(Hart et al., 2017), as well as the core essentials defined by the recently published 
Sanger dataset performed at the Wellcome Trust Sanger Centre (Behan et al., 2019). 
The newly identified common essentials comprise 507 of 686 (74%) of CoreV2 genes 
and 453 of 548 (83%) of Sanger core essentials, while 314 genes were common in all 
approaches (Figure 2.12A). We also examined the gene expression profiles of these 
core essential genes and observed that the 314 genes at the intersection of the three 
approaches have higher median gene expression compared to genes that are 
uniquely core essential in each approach (Figure 2.12B). These observations are 
consistent with an increased false negative rate among essential genes with moderate 
levels of mRNA expression as discussed in the previous section. 
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Figure 2.12. Comparison of 992 common essentials with other “core essentials” show that 
genes unique to each set show bias reflecting the library used. A) Venn diagram comparing 
common essential genes to previously defined gold standard set of core essential genes. B) 
Box plots showing the mean mRNA (TPM) expression of common core essentials (n=314), 
genes unique to new common essentials identified here (n=346), Core V2 specific essentials 
(n=142) and core essential genes specific to the Sanger dataset (n=58). C) Gene Ontology 
(GO) biological process enrichment for core essential genes unique to a specific approach. 
D) Comparison of the distribution of essentiality scores of Sanger specific core essentials in 
common cell lines between the Avana and Sanger data. 
Surprisingly, the core essential genes unique to each dataset showed a strong 
bias reflecting the experimental approach used. We demonstrate that the genes 
unique to common essentials defined in this study are highly enriched for essential 
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processes including ribosome genesis and mRNA processing genes (Figure 2.12C). 
Moreover, genes unique to CoreV2 show a strong bias towards genes encoding 
subunits of the mitochondrial translation and electronic transport chain. As we 
described in Figure 2.10 in section 2.3.4, dependency on these biological processes 
is specific to the cancer subtypes in the dataset, and these genes are likely excluded 
from the Sanger core essentials for the same reason. We did not observe any strong 
functional enrichment among Sanger-specific core essentials, compared to the other 
groups. Among 58 Sanger-specific core essentials, 14 were not targeted in the Avana 
library and the remainder show intermediate BF scores in the 148 common high-
performing Avana screens of the same cell lines (Figure 2.12D, red curve). 
Collectively, these observations are consistent with there being a set of CRISPR 
library-specific false negatives, as previously reported (Ong et al., 2017), which may 
be independent of the expression-associated false negatives discussed in this work. 
 
2.4 Discussion and conclusions 
 
CRISPR technology has revolutionized the field of functional genomics, 
providing an efficient method that leverages endogenous DNA repair machinery to 
achieve gene knockouts on a whole genome scale. Compared to previous 
technologies, CRISPR screens have been shown to detect 3-4 times more essential 
genes at the same false discovery rate (Hart et al., 2014). Extensive use of this 
technology by multiple independent groups has enabled screening of hundreds of 
human cancer cell lines including the DepMap initiative, which is the main source for 
the Avana data examined in this chapter. The vast amount of publicly available human 
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cancer cell line data generated by these efforts enables an opportunity for re-
evaluating the assumptions under which these genome-scale experiments have been 
carried out. One such assumption is that CRISPR screens are saturating and that a 
well-designed single whole genome CRISPR-Cas9 knockout screen can virtually 
detect all the essential genes in that background. However, this notion has not been 
explicitly tested before and it is still poorly understood how the possible systematic 
biases in CRISPR screens affect our understanding of human gene essentiality. 
Furthermore, the true positive, false positive and false negative rates in an average 
genome-wide CRISPR-Cas9 knockout screen are still unknown. 
 
In this chapter, we demonstrated our modeling approaches to estimate the true 
positive rate, false positive rate, and false negative rate from a typical genome-scale 
CRISPR screen. Importantly, these analyses established a baseline for the expected 
number of essential genes and the FDR in an average screen. The model which most 
closely matches data from a large panel of CRISPR screens suggests that a typical 
cell expresses 1,600-1,900 essential genes, but strikingly a single knockout screen 
only detects ~80% of these, and multiple screens are required to saturate the essential 
genes of any tissue or tumor subtype. We showed that hits among highly expressed 
genes are often replicated but false negatives are more prevalent among genes 
expressed at moderate levels. These observations carry severe implications for the 
identification of differentially essential genes, in particular using isogenic cell lines to 
identify synthetic lethal interactions, since it suggests numerous replicates need to be 
screened in order to confidently discriminate cell-line-specific hits from false negatives 
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and false positives. This knowledge is critical for evaluating the significance of findings 
from current experiments as well as for the design of future experiments for gene 
essentiality and synthetic lethality. 
 
Another important implication of the false negative rate that we established is 
that most tissue types carry a larger number of overlapping essential genes than had 
been previously recognized in the field. After allowing for false negatives, we identify 
nearly a thousand genes that are observed across all lineages that are deeply 
sampled in the Avana screens. In contrast, we find only 300-600 tissue-specific genes 
per lineage, with most showing overlap between related tissues. In fact, each tissue 
only carries at most a few dozen tissue-unique genes, and these are enriched for 
lineage-specific transcription factors. 
 
Finally, with these analyses, we established a new set of core essential genes 
and updated our daisy model of gene essentiality using a much more extensive 
heterogeneous set of human cancer cell lines. This improved new set of core essential 
genes are enriched in core essential processes of the cell and like the previous gold 
standard set, can be used as a metric for the quality control of genome-wide CRISPR-
Cas9 knockout screens. Comparing these newly defined genes to previously defined 
gold standard core essential sets, we uncovered CRISPR library-specific false 
negatives showing that a bias exists depending on the library used in these screens. 
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Overall, the analyses in this chapter established some ground truths regarding 
the expected number of essential genes, FDR and FNR in an average screen and 
defined high-confidence sets of core and context essential genes, while revealing 
important sources of bias in genome-wide CRISPR-Cas9 knockout screens. 
 
 
2.5 Methods  
2.5.1 Preprocessing of data with BAGEL 
 
The raw read count file of genome-wide CRISPR pooled library screens for 769 
cell lines using Avana library (Broad DepMap, 2020b; Meyers et al., 2017) (Broad 
Institute’s DepMap Project 20Q2 release), the Avana data, was downloaded from the 
data depository at https://depmap.org/portal/. Concurrently, data from 323 cancer cell 
lines from the Sanger Institute’s Project Score (Behan et al., 2019) was downloaded 
from the data depository at https://score.depmap.sanger.ac.uk/. Both datasets were 
filtered in order to keep only the protein-coding genes for downstream analysis and 
the gene names were updated using Human Genome Organization (HUGO) Gene 
Nomenclature Committee (HGNC) (Braschi et al., 2019) and Consensus Coding 
Sequence (CCDS) (Farrell et al., 2014) databases. sgRNAs targeting multiple genes 
were discarded to avoid genetic interaction effects. The updated raw read counts were 
processed with the CRISPRcleanR (Iorio et al., 2018) algorithm to correct for gene-
independent copy number induced fitness effects and calculate fold change.  
CRISPRcleanR uses a circular binary segmentation algorithm which was previously 
used during the analysis for array-based comparative genomic hybridization assay 
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(Olshen et al., 2004; Venkatraman and Olshen, 2007) and applies it to genome-wide 
CRISPR screens. For each individual chromosome, CRISPRcleanR detects regions 
targeted by multiple sgRNAs with reasonably equal log fold changes (logFCs). If the 
sgRNAs in these regions target a low number of unique genes, this would indicate 
that the phenotype arises due to gene-independent effects and therefore the logFCs 
are corrected through mean or median based centering depending on the presence 
of outliers (Iorio et al., 2018). CRISPRcleanR processed fold changes of each cell line 
were analyzed through updated BAGEL2 algorithm (Kim and Hart, 2021) 
(https://github.com/hart-lab/bagel). Compared to the previous published version of 
BAGEL (Hart and Moffat, 2016), the updated version of BAGEL employs a linear 
regression model to interpolate outliers and uses 10-fold cross validation for data 
sampling. BAGEL is a Bayesian classifier that is trained using previously defined gold 
standard reference sets of core-essential and nonessential gene sets. BAGEL 
estimates the distribution of fold changes of all gRNAs targeting all genes in either the 
essential or nonessential training sets and then it calculates the log likelihood of 
uncharacterized sgRNAs belonging to either the essential or nonessential 
distributions and gives a log Bayes Factor (BF) as the final output (Figure 2.13). 
Essentiality of each gene was measured as BF, which reflects the relative statistical 
confidence of gene essentiality based on gold standard reference sets of 681 core 
essential genes and 927 nonessential genes (Hart et al., 2017, 2014). Positive BF 
indicates essential genes whereas negative BF indicates non-essential genes. The 
list of gold standard core-essential genes and nonessential genes used in this 
dissertation can be found in the same repository as the BAGEL v2 software. The 
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qualities of each screen was evaluated through the “precision-recall” function of 
BAGEL and the F-measure, which is the harmonic mean of the precision recall was 
calculated for each screen at BF of 5. Finally, 659 cell lines for the Broad dataset and 
316 screens for the Sanger dataset were selected for downstream analysis by an F-




Figure 2.13. Bayesian Analysis of Gene Essentiality. A) Kernel density estimate of the log 
fold changes of guides targeting essential genes (red curve) and guides targeting 
nonessential genes (blue curve). B) Histogram showing the distribution of Bayes Factors in a 
screen with blue bars showing nonessential genes and red bars showing the essential genes. 
 
2.5.2 Cumulative Essentials Analysis: 
 
A cumulative analysis approach was used to evaluate and display the 
cumulative distribution of essential genes and calculate the total number of true 
essentials (true positives). As well as the error rate (FDR) in an average CRISPR-
B A  
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Cas9 knockout screen. This approach is based on the principle described previously 
(Hart et al., 2014) that if you screen a sufficient number of cell lines with no false 
positives, you would expect to see a cumulative essential genes observations plot that 
flattens out with a slope of zero when the total number of essential genes is reached. 
However, in reality, if you have some FDR or heterogeneity in the population of cell 
lines being screened, the slope of the cumulative essential plot would stay positive. 
This is because the true hits get saturated but in addition, it is likely that false positives 
as well as cell-line specific context essential genes will also be captured and be added 
on in each consecutive screen. 
 
To perform the cumulative essentials analysis for the screens in the DepMap 
project, herein referred to as the Avana data and the Sanger screens by Project Score, 
the BFs for all genes across all cell lines was constructed in a separate matrix. For 
each of the datasets, the cumulative essentials plot was modeled in any sets of 20 
screens from the dataset. For example, for the Avana data, an initial set of 20 cell lines 
were sampled without replacement and the essential genes in the first screen out of 
20 were identified with a BF of greater than or equal to 10. Then the subsequent 
screen was evaluated to obtain the essential genes in that screen and the newly 
discovered essential genes that were not identified in the prior screen were added to 
the list of essential gene hits to obtain a cumulative essential gene list. The process 
was repeated for all 20 cell lines to capture all cumulative essentials in the 20 screens. 
This random sampling process was repeated 100 times for each dataset to sample 
different cell lines in different orders and prevent bias in the modeling process. The 
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resulting mean cumulative essentials curves were plotted with standard deviations 
reflecting the variability of cumulative essential genes observed in each of 100 
iterations. Moreover, for each iteration, the newly discovered essential genes in each 
set of 20 screens were also identified and displayed on the same plots. 
 
2.5.3 Synthetic genome modeling approach 
 
To estimate the number of essential genes per screen as well as the average 
error rate, in silico simulations of synthetic screens were conducted. First, for each 
dataset, a synthetic genome was constructed with the number of genes assayed in 
that library (i.e. for Avana library N=18,111). For a given genome with N number of 
genes in it, there is a number of true essential genes; represented by n, and number 
of non-essential genes (N-n). Then, the precision (1 - FDR) of the assay is represented 
by the ratio of true positives to that of the total number of hits. We defined a range of 
thresholds for false discovery rate to test in our model from 1-15%. We then randomly 
sampled this synthetic genome with a screen with randomly drawn 1287 hits for the 
Avana dataset (the mean number of essential gene hits at BF>=10 across all Avana 
screens) from the essential (n) and non-essential (N-n) populations based on the 
defined FDR in the simulation (e.g. for 10% FDR, 129 nonessentials and 1,158 
essentials were randomly selected) (Figure 2.14). We observed the cumulative 
essential genes across 8 iterations since we estimated that sampling 8 screens was 
a good estimate of observing the trend in screen saturation in the Avana data. At the 
same time, we constructed a mean cumulative essentials curve determined from the 
Avana data for any 8 screens using bootstrapping for 100 iterations. After running the 
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simulations for a range of different number of essential genes (n) and FDR values, 
cumulative observation curves were plotted for each simulation.  The root mean 
squared deviation for every synthetic screen was calculated by evaluating the 
difference between the observed values and the cumulative essentials curve 
determined from the Avana data (Figure 2.14).   
 
Since both the Avana and Sanger data contains cell lines arising from multiple 
tissue types, it is possible that some of the tissue specific essential genes would be 
wrongly classified as false positives. Therefore, in order to minimize this effect, the 
synthetic genome modeling approach was repeated for individual tissue types which 
were represented by at least 16 high-quality cell lines (as defined by F-measure of 
greater than or equal to 0.8) using the same parameters described above.  
 
All of the analyses were performed using Python version 3.6 using multiple 
packages including pandas (Reback et al., 2020), NumPy (Harris et al., 2020), the 
sklearn.metrics, sklearn.utils, resample modules in SciKits (Buitinck et al., 2013), 
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Matplotlib (Hunter, 2007), seaborn (Waskom et al., 2020) and  scipy (SciPy 1.0 
Contributors et al., 2020). 
 
 
Figure 2.14: Overview of the synthetic genome modeling approach. A synthetic genome 
with N=18111 genes were constructed and 1287 hits were randomly sampled from the 
essential (n) and non-essential (N-n) populations based on the FDR in the simulation. The 
resulting cumulative essential hits across 8 iterations were plotted and compared to the 
mean cumulative essentials curve from the Avana data. 
 
2.5.4 Saturation modeling approach and identification of high 
confidence essential genes 
 
While the in-silico simulations with synthetic genome model enabled an 
estimation of the average number of essential genes per screen with an upper limit 
for the FDR, they didn’t give information about which genes were truly essential. To 
distinguish truly essential genes from false positives, the tissue types in the Avana 
data that were well represented were identified (n>=16 screens). 18 tissue types in 
the Avana data and 9 tissue types in Sanger data fit our criteria and for these tissue 
types, the frequency of essential gene observations in any 8 screens was evaluated 
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separately for each dataset. For each tissue type, a set of 8 initial screens were 
selected, the cumulative essential genes in this set were identified and the frequency 
of essentiality observations was plotted for this set. For the modeling, it was assumed 
that if these first 8 screens have reached saturation (to approximate for our model), 
then the subsequent hits in the next set of screens would give us false positives. 
Therefore, a subsequent set of 8 screens from the same tissue type were randomly 
selected without replacement and the newly discovered cumulative essential genes 
that were not present in the initial screens were identified to model the frequency 
distribution of the false positives. This process was repeated 100 times for each tissue 
type in both datasets and the resulting distribution of essential gene counts in these 
screens were plotted, which were used to calculate the bin-wise FDR. For the 100 
iterations that were performed per tissue type, genes observed as essential in at least 
3 screens on an average out of 8 were considered as high confidence essential genes 
in that tissue. Finally, we assessed how many genes were captured as essential in 
common in all tissues to find the set of “common” essential genes (n=954) and context 
essentials in each tissue type. We used the UpsetR package (Conway et al., 2017) in 
R programming language to visualize the set of intersections of essential genes 
across all tissue types for both of the datasets. 
 
2.5.5 Expression data and analysis 
 
The log2 transformed RNA-seq TPM expression data was utilized from 
DepMap Data Portal for the 2020Q2 release (Broad DepMap, 2020b) for this analysis. 
The mean TPM expression levels were calculated for all genes in each bin in their 
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corresponding cell lines in which the gene was a hit. The process was repeated for all 
the bins from the histogram of the frequency of essentiality observations of the initial 
set of 8 screens representing the true positives and the subsequent set of 8 screens 
representing false positives. 
 
2.5.6 Essentiality profiles of hits in non-essential screens 
In this analysis, we evaluated the mean essentiality scores of genes 
representing true positives in the screens that they were not observed as essential in. 
For each iteration, we determined the screens in which genes in each bin had a BF 
<10 and calculated a mean essentiality score for each gene in those screens. We then 
visualized the distribution of mean essentiality score observations of genes in each 
bin in the non-essential screens as a violin plot using the Seaborn package (Waskom 
et al., 2017).  
2.5.7 Process enrichment analysis for differentiating between 
subtype specific genes vs false negatives 
 
From our modeling of the number of essential genes and false positives per 
tissue type, we had evaluated the frequency of essential gene observations in the 100 
iterations we performed. We constructed a table of mean number of screen 
essentiality observations out of 8 screens, in 100 iterations for every gene in each 
tissue type. To investigate the trends of enrichment of essential pathways, we 
measured the functional enrichment of gene annotations depending on the thresholds 
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for the mean number of screens that a gene was observed as essential in in 0.5 
increments (frequency out of 8 screens). For each threshold, we used the python 
gseapy package version 0.9.11 (Subramanian et al., 2005) for python 3.8 (Van 
Rossum, Guido and Drake, Fred L., 2009) to perform process enrichment in several 
databases including KEGG, CORUM and GO Biological Process using all 18,111 
genes assayed in the Avana library as the set of background genes. Going in 0.5 
increments in the frequency of screen essentiality observations out of 8 screens, we 
plotted the P-value of annotation enrichment for several terms to show the different 
trends in the data. For every gene in the processes that were enriched, we calculated 
their mean TPM expression in their corresponding cell lines for which the process 
enrichment analysis was conducted. Finally, we evaluated the essentiality scores of 
the genes in the enriched pathways in the corresponding cell lines where the mean 
number of frequency of essentiality observation was greater than 0 out of 8 screens. 
We used the seaborn.clustermap function of the seaborn package to plot the 
hierarchically-clustered heatmap of the essentiality scores of the genes in each 
pathway in the corresponding tissue type using the average linkage method and the 
Euclidean distance metric.  
 





Figure S2.1 Cumulative essential genes and newly discovered essentials in each 
tissue type in the Avana data. 
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Figure S2.2. Synthetic genome model applied to other tissue types in the Avana data. White 
boxes indicate models within twice the minimum RMSD. 
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Figure S2.3. Distribution of true positives and false positives in other tissue types in the 

















Table S1. Bin-wise FDRs for each tissue type in the Avana data using saturation modeling 
approach. 
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Chapter 3:  Rescuing false negatives in genome-
wide CRISPR-Cas9 knockout screens 
3.1 Abstract 
 
The analyses in the previous chapter focused on establishing a baseline for the 
expected number of essential genes and an average false discovery rate in an 
average genome-wide CRISPR-Cas9 knockout screen. An important observation that 
came out of these efforts was that the CRISPR screens are not saturating and that 
there is a significant false negative rate that needs to be considered during the 
analysis and interpretation of findings from such screens. Here we describe our 
adjusted priors approach, which can not only rescue the false negatives but also be 
utilized to discover subsets of cell lines that are preferentially dependent on 




Detailed analyses for identification of essential genes through previously gold 
standard methodologies such as the RNAi based genetic screening have revealed 
false negatives mainly due to incomplete knockdown of the target genes that is 
insufficient to induce a fitness defect in human cancer cells (Munoz et al., 2016). 
Although the CRISPR technology enables more accurate and efficient targeting of 
essential genes in genome-wide screens, potential false negative results from these 
screens should be investigated to identify a complete set of essential genes in a given 
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population. While we cannot theoretically measure the true false negative rate of 
CRISPR screens since we do not know definite phenotype of every gene in a tissue 
type, the false negative rate can still be estimated by taking alternative approaches. 
 
In Chapter 2, we examined the cumulative essential genes in the Avana data 
to show that while an average screen captures around 1250-1300 essential genes, it 
takes multiple consecutive screens to identify the total population of essential genes 
using our BAGEL derived essentiality scores (Figure 2.3). This finding also held true 
for individual tissue types in the Avana data with our synthetic genome modeling 
approach, where the expected number of truly essential genes in every tissue type 
was more than the essential genes identifiable in one screen. These observations lead 
to the conclusion that there is an unknown set of essential genes that we are failing to 
detect in these screens, which we define as the false negatives in this chapter. (Figure 
2.7). Moreover, with our saturation modeling approach, we demonstrated that the false 
negatives are more prevalent among moderately expressed genes, leading to a bias 
during the analyses (Figure 2.9; Figure 2.10) and these genes had to be repeatedly 
screened in order to be captured as essential.  
 
Previous studies also investigated the false negative rate in CRISPR screens. 
A study compared data from cell lines screened by different libraries to estimate a 
false negative rate of 14-23% in each library (Ong et al., 2017). This finding is 
consistent with observations from our comparisons between core essential genes 
defined by different approaches, where we had observed library-specific false 
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negatives that are independent of the aforementioned false negatives in an average 
screen.   
 
Regardless of the source of this phenomenon, this chapter will take another 
perspective to demonstrate with examples that a false negative rate exists in CRISPR 
screens and then will describe a computational approach to correct for these genes. 
Then we will discuss what kind of knowledge is added with the rescue of these false 
negatives. Finally, we will show how we can utilize our computational method by 
discovering subgroups of cell lines that are preferentially essential to subsets of genes 




3.3.1 A single genome-wide CRISPR-Cas9 screen cannot detect all 
essential genes in essential protein complexes 
 
In the previous chapter, we demonstrated a significant false negative rate in an 
average genome-wide CRISPR-Cas9 screen (Figure 2.7). Moreover, we also showed 
that these false negative genes tended to be observed in an intermediate number of 
screens in our saturation modeling approach. Here, we will expose the false negative 
problem through essential protein complexes. 
 
Previous studies in model organisms have shown that the individual subunits 
of protein complexes tend to be either all essential or non-essential excluding cases 
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where there might be functional buffering due to redundancy within the complex 
members (Ryan et al., 2013). This notion leads to a model where essential protein 
complexes are formed by essential genes whereas non-essential complexes are 
formed by non-essential genes. Therefore, in human protein complexes, if a complex 
has essential functions, we expect to see all members of that complex to be 
collectively and entirely essential unless there is functional buffering. To see if the 
same trend exists in the Avana data, we looked at previously defined essential protein 
complexes to see how our BAGEL algorithm detects individual essential genes.  
 
The proteosome is a large, essential protein complex responsible for degrading 
intracellular proteins (Tanaka, 2009) and we expect this complex to be essential in all 
cell lines since it carries a core-essential function. In  Figure 3.1A, we see the binary 
essentiality calls (where BF>=10 is considered as essential) of the members of the 
26S proteosome complex as defined in the Comprehensive Resource of Mammalian 
Protein complexes (CORUM) database (Giurgiu et al., 2019) among colorectal cancer 
cell lines in the Avana data. We observed that each individual screen is unable to 
capture all of the individual members of this complex as essential although the 
proteosome is an essential complex. Similarly, in Figure 3.1B, we see the binary 
essentiality calls of the members of another essential, evolutionarily conserved COP9 
signalosome complex which plays a role in controlling protein ubiquitinylation 
(Gutierrez et al., 2020) among Avana colorectal cancer cell lines. Again, we observe 
that not all screens can identify members of this complex as essential. In this complex, 
we don’t observe COPS7A and COPS7B as essential in any screen since as we have 
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previously shown, COPS7A and COPS7B are synthetic lethal paralog pairs and they 
encode alternate, replaceable subunits of the complex, while the other subunits are 
irreplaceable and are uniformly essential (Dede et al., 2020a).  
 
  
Figure 3.1. Binary essentiality calls of essential protein complexes among colorectal cancer 
cell lines in the Avana data based on BAGEL derived essentiality scores. Dark blue color 
indicates essentiality (BF>=10) and white color indicates non-essentiality (BF<10). A) Binary 
essentiality calls of members of 26S proteosome complex. B) Binary essentiality calls of 
members of COP9 signalosome complex among colorectal cancer cell lines in the Avana data 
based on BAGEL derived essentiality scores. 
 
Based on these observations, we proposed that during the analysis of genome-
wide CRISPR-Cas9 knockout screens, in every screen, there is an unknown set of 
A B 
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essential genes that we are failing to detect as essential, leading to a significant false 
negative problem.  
 
We first questioned whether this false negative rate arises due to underlying 
screen quality. Even though we only considered high-performing screens with F-
measure > 0.80 in our analysis, we plotted the F-measure of each screen versus the 
number of non-essential hits within the complex for both the proteosome and COP9 
signalosome complexes. We observed a trend where the screens with lower F-
measures tended to exhibit a higher number of non-essential hits (BF<10) within these 
essential complexes (Figure 3.2). 
 
A B 
Figure 3.2. The relationship between screen quality (F-measure) and the number of non-
essential hits within essential protein complexes. Boxplots showing the distribution of F-
measures of screens versus the number of times a non-essential call was made among 
members of proteosome complex (A) and COPS9 signalosome complex (B). 
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Besides screen quality, we also questioned whether there are library-specific 
false negative protein complexes. As we discussed in section  2.3.6 and in Figure 
2.12D, our saturation modeling had demonstrated that there could be CRISPR-library 
specific false negatives. Comparing the Sanger and Avana datasets, we observed that 
this phenomenon indeed exists as shown for the MCM complex, which is an essential 
complex regulating DNA replication in eukaryotic cells Figure 3.3 (Lei, 2005). While 
multiple Avana colorectal screens fail to capture members of this essential complex 
(based on binary essentiality calls with BAGEL derived BF>10), Sanger colorectal 
screens show more consistent essentiality calls for members of the same complex, 





3.3.2 Overview of the adjusted-priors approach  
 
Having shown that the false negatives exist in CRISPR-Cas9 screens, we 
sought to develop a method to correct for these genes. Before we introduce our 
computational method, we would like to go into some detail on our in-house developed 
BAGEL algorithm. BAGEL is a Bayesian classifier that is trained using pre-defined 
gold standard reference sets of core-essential and nonessential gene sets. BAGEL 
first estimates the distribution of fold changes of all gRNAs targeting all genes in either 
the essential or nonessential training sets and then calculates the log likelihood of 
uncharacterized sgRNAs belonging to either the essential or nonessential 
distributions. The final output of BAGEL is a log Bayes Factor (BF) which represents 
the relative statistical confidence of gene essentiality. The statistical representation of 





This equation can be converted as follows by adding a prior ratio: 
𝑃𝑃𝑁𝑁𝐸𝐸𝐷𝐷𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑁𝑁𝑜𝑜𝑜𝑜𝐸𝐸 =  
Pr (𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝐸𝐸𝐸𝐸𝐸𝐸)
Pr (𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸)




𝑤𝑤ℎ𝑁𝑁𝑃𝑃𝑁𝑁     Pr(𝐸𝐸𝐸𝐸𝐸𝐸) + Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸) = 1 
Performing log transformation, we get: 
Figure 3.3. MCM complex is an example of a CRISPR-library specific false 
negatives. While some members of the MCM complex cannot be captured as 
essential in multiple colorectal screens in the Avana dataset (left), the complex 
shows more uniform essentiality in Sanger colorectal cell lines (right).  
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𝑃𝑃𝑁𝑁𝐸𝐸𝐷𝐷𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 log 𝑁𝑁𝑜𝑜𝑜𝑜𝐸𝐸 = log(𝐵𝐵𝐵𝐵) + log (𝑝𝑝𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) 
 
Based on prior information from genome-wide CRISPR-Cas9 knockout 
screens regarding the number of essential genes in a given genome, we consider  
Pr(𝐸𝐸𝐸𝐸𝐸𝐸) = 0.1 (ie. the background expectation of gene essentiality in humans is 10%), 
which yields Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸) = 0.9  and therefore we have: 
log(𝑝𝑝𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) = log �
Pr (𝐸𝐸𝐸𝐸𝐸𝐸)
Pr (𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸)�
= ~ − 3 
 
While using our BAGEL algorithm, we traditionally use this flat prior ratio of -3 
during BF calculations for all screens. In order to rescue the false negative genes we 
observed during our analysis, and to differentiate between false negative genes and 
subtype-specific genes, we employed an alternative method called adjusted priors 
approach. In this approach, instead of using a flat prior of -3 for all screens, we update 
this prior ratio as we gain observations from the screens. And instead of using 
essentiality scores, BFs for each gene, we assigned a binary call to each gene based 
on posterior probability of essentiality, after updating the probability of essentiality of 
each screen based on prior observations. 
 
First, we revisited our saturation modeling approach described in 2.3.3, where 
we evaluated sets of 8 initial and 8 subsequent screens to model the distribution of 
true positive essential genes and false positives to calculate a bin-wise FDR for each 
of the 8 bins. 
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Specifically, we evaluated sets of 8 screens at a time in each tissue type. For 
each gene, we ranked the screens from the highest BF to lowest in each set. Next, for 
the top cell line in which the gene had the highest BF, we calculate the posterior 
probability of essentiality for that gene. Since we don’t have any prior data for the 
observations for this screen, we use the initial log prior ratio of -3 and assign a binary 
call of essentiality of 1 if the BF >10 based on posterior log(odds) of 7 which 
corresponds to a posterior Pr(ess) of 99%. We chose a strict posterior log odds ratio 
of 7 to have high confidence binary essentiality calls with posterior Pr(ess) ~99% in 
our analysis. Next, we move on to the next screen if the screen gets an essential 
binary call in the first screen, For the next screen where the gene has the second 
highest BF, the prior is now based on having observed this gene as essential in the 
previous screen assuming that these screens are related. And for the log prior ratio, 
instead of using Pr(Ess) of 0.1 and Pr(Noness) of 0.9, we use the bin-wise FDR values 
from the saturation modeling approach (Table S1). Given an observation of having 
this gene as essential in 1 screen, we questioned the probability of whether this is a 
true observation. Using the corresponding bin-wise FDR belonging to a tissue, for this 
second cell line, we substituted the log(𝑃𝑃𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) with log (1−(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑏𝑏𝑏𝑏 𝑏𝑏𝑏𝑏𝑏𝑏1)
(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑏𝑏𝑏𝑏 𝑏𝑏𝑏𝑏𝑏𝑏1)
). For 
example, if the bin-wise FDR is 50% for the first bin, we get: 
 
log(𝑃𝑃𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) = log�
1 − (0.5)
(0.5)
� = 0 
Again, using a log odds ratio of 7 to ensure 99% probability of essentiality: 
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𝑃𝑃𝑁𝑁𝐸𝐸𝐷𝐷𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 log 𝑁𝑁𝑜𝑜𝑜𝑜𝐸𝐸 = log(𝐵𝐵𝐵𝐵) + log (𝑝𝑝𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) 
   7 = log(𝐵𝐵𝐵𝐵) + 0 
 
Therefore, a BF>7 will indicate that the probability of essentiality is ~99%, 
resulting in a binary call of essentiality of 1. If the gene is again assigned as an 
essential gene, then this process goes on for the third screen, using the bin-wise FDR 
values from the second bin in the saturation modeling approach. The assignment of 
binary calls end once all 8 screens are evaluated. Since the bin-wise FDR values are 
almost negligible for certain bins as we have shown in the saturation modeling 
approach, we capped the prior log ratio at 9 so that the BF threshold does not become 
too low while ensuring high probability of essentiality. In addition, to ensure that all cell 
lines are properly sampled, we repeated the sampling process 100 times, selecting 8 
different screens in each iteration from every tissue type to minimize bias. For every 
tissue type, we recorded all binary calls for all genes in 100 iterations as well as the 
cell lines that were sampled in each iteration. 
 
 
3.3.3 Adjusted priors approach identifies a higher number of 




After applying our adjusted priors approach to all tissue types in the Avana and 
Sanger data, we compared the observations in both datasets to our saturation 
modeling approach to evaluate how the bin-wise distributions of hits changed. We 
observed that the adjusted priors approach resulted in a rightward shift towards a 
higher frequency of gene essentiality calls, with lower number of hits in the first bins 
and much higher number of hits in the eighth bin compared to the saturation modeling 
approach (Figure 3.4A for Avana data). Genes that had a higher frequency of 
observations (6 or higher out of 8) were skewed towards the eighth bin while the genes 
that were in the lower frequency bins (enriched in false positives) were not boosted to 
higher bins with our adjusted priors approach. We observed a similar trend in the 
Sanger dataset as well (Figure S3.1). 
Figure 3.4. Adjusted priors approach identifies more essential genes in Avana genome-wide 
CRISPR-Cas9 knockout screens compared to saturation modeling approach. A) Comparison 
of the frequency of essential gene hits in saturation modeling versus adjusted priors approach. 
B) Comparison of violin plots showing the distribution of the essentiality scores (Bayes Factor, 
BFs) of the hits in A, in the screens where they were not observed as essential. 
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During our analyses in our saturation modeling approach, we had evaluated 
the essentiality scores of the hits in the screens that they were not essential in. We 
had observed that the more frequently a gene is captured as essential, the higher its 
average BF was in screens where it is not essential Figure 2.9C. This observation 
was strongly consistent with false negatives. Therefore, we performed the same 
analysis after applying our adjusted priors approach to see if we could rescue the 
trend we observed in saturation modeling. As shown in Figure 3.4B, we observed that 
hits in our adjusted priors approach tended to have consistently negative BFs in the 
screens that they were not essential in indicating that the false negatives have been 
rescued.  
 
One question that arises from our adjusted priors approach is whether the false 
positive rate also increases as we rescue false negatives in our screens. To determine 
if this is the case, we compared the number of hits as well as the number of false 
positive genes detected across colorectal cancer cell lines in Avana data when binary 
essentiality calls are made using a BF threshold of 10 vs BF of 5 and a mean adjusted 
priors call of 1 across all iterations in that cell line. The false positive genes were 
defined based on CCLE log(TPM) expression <1 in a given cell line. We observed that 
adjusted priors method detects a significantly higher number of essential gene hits 
compared to a binary called based on BF>10 (t-test ind. samples with Bonferroni 
correction, p-value=6.989e-05), while lowering the BF threshold to 5 results in a non-
significant increase in the number of hits compared to adjusted priors method (Binary 
BF5 vs. Adj. priors: t-test ind. samples with Bonferroni correction, p-value=7.904e-02) 
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(Figure 3.5A).  Moreover, we observed that although the number of false positives 
detected with adjusted priors (mean=50) is higher than those detected with binary 
calls using BF>10 (mean=38) in colorectal cancer cell lines (t-test ind. samples with 
Bonferroni correction, p-value=1.114e-02), the increase is still less significant 
compared to the number of false positives obtained after lowering the BF threshold to 
5 (mean=77, Binary BF10 v.s. Avana_binary_BF5: t-test ind. samples with Bonferroni 
correction, p-value=2.082e-07)(Figure 3.5B). These findings indicate that the adjusted 
priors method can detect more essential genes thus recuing false negatives without a 
drastic increase in the number of false positives detected per screen compared to 
lowering the BF threshold to 5. 
 
 
Figure 3.5. Adjusted priors can rescue the false negatives with a less significant 
increase in false positives compared to assigning binary calls using a lower BF 
threshold. A) The number of essential gene hits using binary calls indicated by 
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different thresholds indicated on the x axis. B) The number of false positive genes 
detected across colorectal cancer cell lines in the Avana data using different 
thresholds indicated on the x axis. P-value annotation legend as follows; ns: 0.05 <p, 




3.3.4 Adjusted priors rescues false negatives, increasing the 
enrichment of essential processes among high frequency hits 
 
Next, we investigated the number of false negatives we rescued in a bin-wise 
fashion using our adjusted priors approach. After calculating the mean adjusted priors 
essentiality calls out of 8 screens for 100 iterations, we plotted the delta shift in the 
frequency of observations out of 8 screens with the adjusted priors approach versus 
the saturation modeling frequencies. We observed that the genes in lower frequency 
of observations (lower bins) in saturation modeling approach tended to display low 
delta bin values, staying in lower bins and indicating that their frequency observations 
are not boosted by our approach (Figure 3.6). However, genes in high frequency bins 
(bin 5 and higher in saturation modeling approach) tended to show a higher delta and 





Figure 3.6. Delta-shift in frequency of observations out of 8 screens with adjusted 
priors approach (y-axis) compared to saturation modeling approach (x-axis) for the 
colorectal cancer cell lines in the Avana data. Red line indicating bins which comprise 
the false negative genes. 
 
For our downstream analysis, we defined false negative genes as the ones that 
were assigned to the eighth bin (mean essentiality frequency >=7.5 out of 8 screens 
with adjusted priors) excluding those that were already in the eighth bin in the 
saturation modeling approach in each tissue type (indicated by the red diagonal line 
in Figure 3.6 for colorectal cancer cell lines in the Avana data as an example). We 
also repeated the same process for the Sanger dataset. First, we evaluated whether 
these false negative genes contained any members of the essential protein complexes 
 87 
we showed in section 3.3.1 Figure 3.1. We observed that our adjusted priors approach 
rescued several members of the proteosome and COPS complexes (false negative 






Figure 3.7. Adjusted priors approach rescues previously missed false negative genes 
in essential protein complexes. Binary essentiality calls based on BAGEL derived 
BF>=10 of proteosome complex (A) and COPS complex (B) among colorectal cancer 
cell lines in the Avana data. The false negative genes rescued with the adjusted priors 
approach are indicated with orange boxes for both protein complexes. 
A B 
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Next, we questioned whether the false negatives that we have observed and 
rescued with our adjusted priors approach is a general phenomenon or a library 
specific problem. We evaluated the overlap of the false negatives we identified in the 
Avana and Sanger screens, high frequency hits in the eighth bin in both datasets as 
well as the overlap obtained when the false negatives are combined with the high 
frequency hits. As shown for the colorectal cancer cell lines in the Avana and Sanger 
datasets in Figure 3.8, we observed that while the false negatives in both datasets 
alone and the high frequency hits in the saturation modeling approach (eighth bin) 






Figure 3.8. False negatives are not a library-specific phenomenon. Top-left: Venn-
diagram showing the overlap of the false negative genes among colorectal cancer cell 
lines in Avana and Sanger datasets. Top-right: The overlap of genes with high 
frequency observations (bin 8) in saturation modeling approach among colorectal 
cancer cell lines in both datasets. Bottom: Combination of false negative genes with 
high frequency hits in saturation modeling approach in both datasets. 
 
We then investigated whether the rescued false negatives are involved in the 
same pathways as the high frequency hits. We performed process enrichment for the 
sets shown in Figure 3.8 and observed that the false negative genes indeed increase 
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the enrichment of the essential processes among high frequency hits in the saturation 
modeling approach. This indicates that more members of these essential pathways 
are captured with the addition of false negatives resulting in a more comprehensive 
set of high confidence, high frequency hits in both datasets (Figure 3.9). 
 
Overall, these analyses show that our adjusted priors approach is able to 
rescue false negative genes from essential pathways and improves the concordance 










Figure 3.9. The recovered false negatives increase the enrichment of essential 
biological processes in colorectal cell lines among high frequency hits defined in 
saturation modeling approach. Top: Avana colorectal cell lines. Bottom: Sanger 
colorectal cell lines. Blue bars indicate the enrichment among high frequency hits in 
saturation modeling and orange bars depict the increase in enrichment with the 
addition of false negative genes. 
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3.3.5 Adjusted priors approach can detect sub-groups of cancer 
cell lines that are preferentially dependent on functionally coherent 
groups of genes 
 
Finally, we investigated whether the binary essentiality calls we made through 
the adjusted priors approach can be used to provide any insights into detecting cancer 
subtype specific modules. Since our adjusted priors approach evaluates essentiality 
across 8 sampled screens at a time within a tissue type, we had to take an alternative 
approach in order to obtain cell line specific assignments. We converted these tissue 
level scores (frequency of observation out of 8 screens) to cell line specific 
assignments by calculating the total number of times a binary call of 1 (indicating the 
gene is essential) was made for each gene in each cell line across 100 iterations and 
then normalizing by how many times that cell line was chosen in our 100 iterations.  
With this method, we obtained a normalized binary essentiality call at a cell line level 
that ranged from 0 to 1 for each gene. 
 
Next, we used these normalized calls to look for subsets of cell lines of the 
same tissue type that are preferentially essential to subsets of genes to look for 
functionally coherent modules. After removing genes that were consistently 
nonessential and highly essential across all cell lines within a tissue type, we 
performed hierarchical clustering of the cell lines to observe whether the clusters 
would represent cancer specific subtypes.  
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We first evaluated at the colorectal cancer cell lines in the Avana data and 
clustered the genes based on their normalized adjusted priors calls. We also added 
the Consensus Molecular Subtypes (CMS) of colorectal cancer information as defined 
previously (Guinney et al., 2015). 
 
Figure 3.10. Hierarchical clustering of colorectal cancer cell lines and genes with 
mean normalized adjusted priors calls between 0.3 and 0.7. The colorectal cancer cell 
lines are color coded using the CMS subtyping. 
 
 The CMS classification was previously defined to integrate gene expression 
profiles of colorectal carcinoma samples from different stages. It is divided into four 
subtypes from CMS1 to CMS4 where each of the subtypes are thought to represent 
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a characteristic molcular profile. For example the CMS1 tumors exhibit strong immune 
acivation and higher mutation rates, CMS2 tumor show a typical Beta catenin 
activation representign epithelial cancers while the CMS3 shows dysregulation of 
metabolic genes and CMS4 represent mesenchymal tumors with poorest survival 
(Thanki et al., 2017). 
 
As seen in Figure 3.10, using our normalized adjusted priors calls, the 
colorectal cancer cell lines in the Avana data clustered into separate groups with 
mainly CMS2 and CMS4 cell lines clustering separately from CMS1 and CMS3. We 
noticed that a gene cluster in the plot seemed to be roughly essential in about half of 
the cell lines, therefore we sought to explore whether these genes were enriched in a 
particular pathway.  
 
A closer examination of this cluster with process enrichment showed that the 
cell lines mainly separated into two groups based on the essentiality profiles of a 
























Figure 3.11. Gene cluster enriched in mitochondrial translation pathway among 
colorectal cancer cell lines in Avana data. Top: Hierarchical clustering of the colorectal 
cancer cell lines bases on mean normalized adjusted priors calls of the gene cluster. 
Bottom: Process enrichment of genes in cluster using GO Biological Process 2018 gene 
sets.  
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Our analysis showed that the genes involved in the mitochondrial translation, 
respiratory chain signal and related pathways appeared in every tissue type and was 
suppressing the other phenotypes in the data. We therefore questioned whether these 
processes are due to another source of  bias in the data. We obtained the doubling 
times of the CCLE cell lines and looked at the relationship between the essentiality 
scores of the genes involved in the aforementioned pathways and doubling hours of 
the cell lines in CCLE. We observed that the mean Bayes factors of the genes involved 
in these processes are negatively correlated to the doubling times of the cell lines 
indicating that the phenotype we are observing is due to a bias related to the growth 




Figure 3.12. Cellular doubling times are a source of bias towards genes related to 
mitochondrial translation related processes in the data. 
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To mitigate for this effect, we removed genes related to mitochondrial 
translation and oxidative phosphorylation related pathways and performed clustering 
again in order to find subsets of cell lines that are preferentially dependent on 
functionally coherent gene groups. Among colorectal cancer cell lines, we observed 
that while the CMS1 and CMS3 cell lines are dependent on a group of genes enriched 
in tRNA processing and tRNA modification pathways, the mesenchymal CMS4 cells, 
which have poor prognosis, do not exhibit the same dependency on this subgroup of 




















Figure 3.13. CMS1 and CMS3 colorectal cancer cell lines show preferential dependence on 
tRNA processing and tRNA modification pathways while the CMS4 subtype does not show 
a similar dependency. Top: Hierarchical clustering of the colorectal cancer cell lines using 
the mean normalized adjusted prior calls of genes indicated on y-axis. Bottom: Process 
enrichment of genes in clusterogram using GO Biological Process 2018 gene sets.  
 99 
Similarly, we evaluated the breast cancer cell lines to discover if the cell lines would 
cluster based on previously defined breast cancer subtypes. Again, after removing 
mitochondrial translation and related genes, we observed that that the more 
differentiated luminal and HER2 amplified breast cancer cell lines clustered separately 




Figure 3.14. Breast cancer cell lines in Avana. Luminal and HER2 amplified cell lines form 
their own cluster while the basal subtypes cluster separately. Cells lines are color coded 
according to the breast cancer subtypes defined in the DepMap project. 
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We then zoomed into some of the trees observed in Figure 3.14, and demonstrated 
the differential essentiality of the luminal and HER2 amplified subtypes on estrogen 
pathway and G2/M transition while the basal subtype breast cancers do not show any 





Another cluster we observed belongs to a group of genes that are enriched in integrin 
mediated signaling pathway that controls metastasis and which is preferentially 




Figure 3.15. Luminal and HER2 amplified cell lines are dependent on a subset of genes 
involved in G2/M transition and estrogen receptor signaling pathway. Top: Hierarchical 
clustering of breast cancer cell lines in Avana using the mean normalized adjusted priors 
calls of a group of genes. Bottom: Process enrichment of genes in the above cluster. 
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Figure 3.16. Subset of breast cancer cell lines show differential essentiality for a group of 
genes enriched in integrin mediated signaling pathway. Top: Hierarchical clustering of breast 
cancer cell lines in Avana using the mean normalized adjusted priors calls of a group of genes. 
Bottom: Process enrichment of genes in the above cluster. 
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We made another interesting observation in the lung tissue, where we see a 
group of non-small cell lung adenocarcinoma cell lines being dependent on 
peroxisomal and fatty-acid oxidation genes (Figure 3.17). In this cluster we show the 
differential essentiality of ACOX1 and HSD17B4 genes which carry out the enzymatic 
steps in the process of peroxisomal fatty acid oxidation. Moreover, we also observe 

























Figure 3.17. A group of non-small cell lung adenocarcinoma cell lines exhibit differential 
essentiality for genes involved in peroxisomal and fatty acid oxidation pathways. Top: 
Hierarchical clustering of lung cancer cell lines in Avana using the mean normalized adjusted 




Interestingly, these observations are consistent with our findings from our 
human co-essentiality network (Kim et al., 2019). In this work, we had constructed a 
network of genes with correlated essentiality scores and showed that these correlated 
fitness profiles could be used to infer shared biological function since they are 
analogous to having correlated genetic interaction profiles. With our network, we were 
able to identify clusters of genes with functional coherence using gene co-essentiality 
profiles. One such example was the peroxisomal beta-oxidation cluster that is 
depicted in Figure 3.18A which contains several genes involved in peroxisomal fatty 
acid beta oxidation and peroxisome biogenesis (Figure 3.18B). The members of this 
cluster show a pattern of differential co-essentiality in 6 out of 42 lung cancer cell lines 
in the earlier release of the Avana data (Figure 3.18C), consistent with our 












Figure 3.18. Peroxisome cluster in the human co-essentiality network. A) A group of genes 
involved in peroxisome (orange) is inter-connected with edges that show high correlation 
(blue) in the human co-essentiality network. B) Genes in the PEX cluster are composed of 12 
genes with two enzymes responsible for fatty acid oxidation reactions and 10 other genes 
involved in peroxisomal biogenesis and maintenance. C) The PEX cluster in the co-
essentiality network shows differential essentiality in a subset of lung cancer cell lines in the 
initial release of Avana data. (E. Kim, M. Dede, W. Lenoir, G. Wang, S. Srinivasan, M. Colic, 
T. Hart, A network of human functional gene interactions from knockout fitness screens in 
cancer cells. Life Sci Alliance, 2019. 2(2). Figure used with permission from Eiru Kim, Ph.D. 
Copyright permissions are not required. This article is available under a Creative Commons 
License – https://creativecommons.org/licenses/by/4.0/). 
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3.4 Discussion and conclusions 
 
CRISPR-Cas9 technology has proven to be to be the gold standard method to 
detect essential genes, discovering a significantly increased number of essentials 
compared to previous technologies at the same false discovery rate. Using this 
technology to conduct whole genome screens in hundreds of cancer cell lines, we and 
others have identified cancer specific essential genes. However, in practice, each lab 
does not perform experiments in a large number of screens. Although biological and 
technical replicates are routinely included, it is impractical for each experiment to be 
conducted in hundreds of cell lines or with dozens of replicates. Therefore, it is crucial 
to know about the limitations during the analysis of experiments conducted with this 
technology, especially when driving conclusions from experiments performed in a 
limited number of screens. 
 
During our extensive analysis of cell lines from both the DepMap project and 
Project Score, we demonstrated a significant false negative problem during the 
analysis of whole genome CRISPR-Cas9 knock out screens. As shown with the core 
essential protein complexes which are expected to be composed of essential genes, 
a single screen in a cell line is unable to detect all members of these essential 
complexes. This indicates that a single experiment cannot detect all essential genes 
in that background, which creates a limitation during the interpretation of the results 
from these screens. 
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In order to address this significant limitation and to improve our understanding 
of gene essentiality, we developed our adjusted priors approach. In this method, 
instead of using a flat prior based on the background probability of a gene being 
essential as 10%, we updated this prior ratio based on the previous observations we 
made from the saturation modeling approach of the Avana data where we had 
established bin-wise false discovery rates for each frequency of essentiality 
observations across multiple tissue types. Using these updated priors, for each gene 
we calculated the posterior probability of essentiality and assigned a binary 
essentiality call instead of continuous mapping with Bayes factors. 
 
Our method resulted in an increased number of genes with high frequency 
observations, thus a greater number of high confidence essential genes when we 
compared the outcomes of the adjusted priors with saturation modeling approach 
(Figure 3.4A). Moreover, the essentiality profiles of the hits in non-essential screens 
showed negative Bayes factors, indicating that these genes were indeed non-
essential in those screens (Figure 3.4B). With our analysis among the essential 
protein complexes, we showed that our adjusted priors approach was able to rescue 
several false negative genes which appeared to be deemed non-essential in individual 
screens using binary calls made using BAGEL derived BF>=10 threshold (Figure 3.7). 
These findings carry significant implications for the identification of the total population 
of essential genes in a given context as they suggest that our computational method 
offers a cleaner analysis of the data, correcting for the previously unidentified false 
negatives. 
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By evaluating the shift in observations of the adjusted priors with saturation 
modeling, we defined the false negative genes in each tissue type. We observed that 
the addition of false negatives to the highest frequency hits (8 out of 8 screens) 
increased the enrichment of essential processes demonstrating that more members 
of these essential processes were captured using adjusted priors. Furthermore, the 
application of this method to both the Avana and Sanger datasets increased the 
number of common hits between the observations in these two independent 
approaches, resulting in a higher concordance between the datasets. 
 
Fortunately, the detection of a greater number of essential genes with adjusted 
priors does not come with an unwanted side effect of a detrimental increase in the 
number of false positives. Compared to the number of essentials detected with 
different BF thresholds, adjusted priors detects significantly more essentials than 
those with BF>10, while lowering the threshold to BF>5 does not cause a significant 
increase than the adjusted priors (Figure 3.5). Strikingly, the mean number of 
essential genes detected with adjusted priors among colorectal cancer cell lines 
(N=1565) is approximately what we had predicted in section 2.3.2 using our synthetic 
genome modeling for the same tissue type (N=1600) (Figure 2.6), indicating the 
consistency of our findings using different approaches. 
 
Furthermore, the utility of the adjusted priors approach goes beyond 
addressing the false negative problem. Besides uncovering the false negatives in 
each tissue type, adjusted priors approach can distinguish cancer subtypes in a 
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modular fashion. We applied our method to identify subgroups of cell lines that exhibit 
preferential essentiality to subsets. We observed that indeed clusters of cell lines, 
which corresponded to previously defined cancer subtypes showed dependence of 
gene sets which showed functional coherence. Our examples in multiple tissue types 
indicate that our data driven approach can discriminate between false negatives 
versus subtype specific essential genes which are highly essential in a subgroup of 
cell lines.  
 
Our lab has previously constructed the coessentiality network from human cell 
lines where genes with correlated essentiality scores are used to infer correlated 
genetic interaction profiles (Kim et al., 2019). With the coessentiality network, we were 
able to identify clusters of coessential genes that are functionally coherent. However, 
the coessentiality network does not address the question of what subtypes are present 
since the purpose of the network was to infer gene function. In this work, using an 
independent approach, our adjusted priors method enabled us to investigate genes 
that are essential in some fraction of cells and are functionally coherent within those 
groups regardless of their coessentiality. Ultimately, we were able to find modules that 
are consistent with observations from the coessentiality network, with subsets of cell 
lines that are preferentially essential to sets of genes which show functional 
coherence. Thus, our method offers an avenue for data driven discovery of subtypes 




3.5.1 Preprocessing of data with BAGEL 
The Avana dataset processing was performed using the same methodology 
described in section 2.5.1 to obtain BAGEL derived essentiality scores for each gene 
in every screen. 
 
3.5.2 Adjusted-priors approach  
In order to explain the methodology behind our adjusted priors approach, we 
need to re-visit some details about our BAGEL algorithm. The output of BAGEL is 
the Bayes factor (BF), the statistical representation of which can be displayed with 





The BF allows the transform to posterior odds and therefore enables the 
conversion of these scores to a probability of essentiality which in turn allows us to do 
a binary classification of gene essentiality instead of continuous mapping. Therefore 
the posterior odds can be obtained by multiplying the BF with the prior ratio as shown 
below: 
 
𝑃𝑃𝑁𝑁𝐸𝐸𝐷𝐷𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑁𝑁𝑜𝑜𝑜𝑜𝐸𝐸 =  
Pr (𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝐸𝐸𝐸𝐸𝐸𝐸)
Pr (𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸)








Performing log transformation, we get: 
𝑃𝑃𝑁𝑁𝐸𝐸𝐷𝐷𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 log 𝑁𝑁𝑜𝑜𝑜𝑜𝐸𝐸 = log(𝐵𝐵𝐵𝐵) + log (𝑝𝑝𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) 
 
Based on prior information from genome-wide CRISPR-Cas9 knockout 
screens regarding the number of essential genes in a given genome, BAGEL 
considers  Pr(𝐸𝐸𝐸𝐸𝐸𝐸) = 0.1 (ie. the background expectation of gene essentiality in 
humans is 10%), which yields Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸) = 0.9  and therefore we have: 
log(𝑝𝑝𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) = log �
Pr (𝐸𝐸𝐸𝐸𝐸𝐸)
Pr (𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐸𝐸𝐸𝐸)�
= ~ − 3 
The relationship between the posterior probability of essentiality and BFs can 
be seen in the figure below (Figure 3.19). And as Table 1 indicates, Bf of 10 
corresponds to a posterior probability of essentiality of ~99% and that is why we used 














Table 1. Bayes factors vs the posterior probability of essentiality. 
 
During BF calculations with our BAGEL algorithm, we traditionally use this flat 
prior ratio of -3 for all screens. However, our adjusted priors method relies on the 
notion that this prior ratio gets updated as we gain more observations from the 
available data. The final outcome is a binary essentiality call for each gene based on 
the posterior probability of essentiality instead of a BF.  
 
First, we revisited our saturation modeling approach described in 2.3.3, where 
we evaluated sets of 8 initial and 8 subsequent screens to model the distribution of 
true positive essential genes and false positives to calculate a bin-wise FDR for each 
of the 8 bins. Specifically, we evaluated sets of 8 screens at a time in each tissue type. 
For each gene in this set, we ranked the screens from the highest BF to lowest. Next, 
for the top cell line in which the gene had the highest BF, since we don’t have any 
prior data for the observations for this screen, we used the initial log prior ratio of -3 
and assigned a binary call of essentiality of 1 if the BF >10 based on posterior 
log(odds) of 7 which corresponds to a posterior Pr(ess) of 99%. Throughout the 
analysis, we kept this strict posterior log odds ratio of 7 to have high confidence binary 
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essentiality calls with posterior Pr(ess) ~99%. Next, for the second screen where the 
gene had the second highest BF, the prior is now based on having observed this gene 
as essential in the previous screen assuming that these screens are related (ie the 
cell lines from the same tissue types). And we used information from the the bin-wise 
FDR values we calculated from the saturation modeling approach. Therefore, using 
the corresponding bin-wise FDR belonging to a tissue, for this second cell line, we 
substituted the log(𝑃𝑃𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) with log (1−(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑏𝑏𝑏𝑏 𝑏𝑏𝑏𝑏𝑏𝑏1)
(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑏𝑏𝑏𝑏 𝑏𝑏𝑏𝑏𝑏𝑏1)
). For example, if the bin-
wise FDR is 50% for the first bin, we get: 
 
log(𝑃𝑃𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) = log�
1 − (0.5)
(0.5)
� = 0 
Again, using a log odds ratio of 7 to ensure 99% probability of essentiality: 
𝑃𝑃𝑁𝑁𝐸𝐸𝐷𝐷𝑁𝑁𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 log 𝑁𝑁𝑜𝑜𝑜𝑜𝐸𝐸 = log(𝐵𝐵𝐵𝐵) + log (𝑝𝑝𝑃𝑃𝑃𝑃𝑁𝑁𝑃𝑃 𝑃𝑃𝐷𝐷𝐷𝐷𝑃𝑃𝑁𝑁) 
   7 = log(𝐵𝐵𝐵𝐵) + 0 
 
Therefore, we assigned a binary call of essentiality to this gene in this cell line, 
if BF>7, indicating that the probability of essentiality is ~99. Then we repeated the 
process for all 8 screens, using the corresponding bin-wise FDR values from the 
previous observations. Since the bin-wise FDR values are almost negligible for certain 
bins as we have shown in the saturation modeling approach, we capped the prior log 
ratio at 9 so that the BF threshold does not become too low while ensuring high 
probability of essentiality. We repeated the sampling process 100 times, selecting 8 
different screens in each iteration from every tissue type to minimize bias. For every 
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tissue type, we recorded all binary calls for all genes in 100 iterations as well as the 
cell lines that were sampled in each iteration. All of the analyses were performed using 
Python version 3.6 using multiple packages including pandas (Reback et al., 2020), 
NumPy (Harris et al., 2020), the sklearn.metrics, sklearn.utils, resample modules in 
SciKits (Buitinck et al., 2013), Matplotlib (Hunter, 2007), seaborn (Waskom et al., 
2020), scipy.stats module in scipy (SciPy 1.0 Contributors et al., 2020) 
 
3.5.3 Evaluation of essential protein complexes 
Essential protein complexes were downloaded as they are defined in the 
comprehensive resource of mammalian protein complex (CORUM) database (Giurgiu 
et al., 2019). The Bayes factors of the genes in each complex was binarized using 
BF>10 to identify non-essential members of each complex according to thresholding 
using BAGEL to demonstrate the false negative problem in these essential 
complexes. 
 
3.5.4 Identification of false negative genes in tissues 
Mean frequency observations out of 8 screens in adjusted priors approach 
were compared to those from the saturation modeling approach described in section 
2.3.3 for both the Avana and Sanger screens. The observations were binned from 
each approach and genes that were placed in the eighth bin in the adjusted priors 
approach excluding those that were already placed in the eighth bin in the saturation 
modeling approach were defined as false negatives in a tissue type.  
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3.5.5 Detecting subgroups of cell lines with adjusted priors 
approach 
 
For this analysis, we converted our tissue level mean frequency adjusted priors 
calls to cell line level binary calls. For each gene in every cell line, we first calculated 
the total number of binary calls made across 100 iterations and then we normalized 
by the number of times each cell line was chosen across 100 iterations to get a mean 
cell line level adjusted prior call. Prior to clustering, for each tissue type, we removed 
genes with mean binary adjusted priors calls <0.2 and genes with mean binary 
adjusted priors calls >0.8 across all cell lines from a particular tissue type in order to 
capture genes with high variance of calls. We then performed hierarchical clustering 
of the cell lines from each tissue type using the cell line level mean adjusted priors 
calls using seaborn.clustermap function of the seaborn package with Euclidean 
distances and ward metric. 
 
 










Figure S3.1. Adjusted priors approach shows similar trends in the Sanger dataset. A) 
Comparison of the frequency of essential gene hits in saturation modeling versus adjusted 
priors approach in colorectal cancer cell lines Sanger dataset. B) Violin plots showing the 
distribution of the essentiality scores (Bayes Factor, BFs) of the hits, in the screens where 
they were not observed as essential using adjusted priors approach. C) Delta-shift in 
frequency of observations out of 8 screens with adjusted priors approach (y-axis) compared 








Chapter 4:  Blind-spots in genome-wide CRISPR-
Cas9 knockout screens 
The work in this chapter has been adapted from the following publication: 
Dede, Merve, Megan McLaughlin, Eiru Kim, and Traver Hart. "Multiplex 
enCas12a screens detect functional buffering among paralogs otherwise masked in 
monogenic Cas9 knockout screens." Genome biology 21, no. 1 (2020): 1-19.  
Copyright permissions are not required. This is an open access article 
distributed under the terms of the Creative Commons CC BY license: 
https://creativecommons.org/licenses/by/4.0/. 
 
So far, we have conducted an extensive analysis of genome-wide CRISPR-
Cas9 knockout screens to accurately detect essential genes in human cancer cell 
lines. We demonstrated all the useful information we can learn from these screens, 
including the biases we observed and the false negatives we rescued. This chapter 
will focus on what is missing from these datasets; the blind-spots in CRISPR screens. 
 
4.1 Abstract 
Major efforts on pooled library CRISPR knockout screening across hundreds 
of cell lines have identified genes whose disruption leads to fitness defects, a critical 
step in identifying candidate cancer targets. However, the number of essential genes 
detected from these monogenic knockout screens are very low compared to the 
number of constitutively expressed genes in a cell, raising the question of why there 
are so few essential genes. Through a systematic analysis of screen data in cancer 
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cell lines generated by the Cancer Dependency Map, we observed that half of all 
constitutively-expressed genes are never hits in any CRISPR screen, and that these 
never-essentials are highly enriched for paralogs. We investigated paralog buffering 
through systematic dual-gene CRISPR knockout screening by testing algorithmically 
defined ~400 candidate paralog pairs with the enCas12a multiplex knockout system 
in three cell lines. We observed 24 synthetic lethal paralog pairs which have escaped 
detection by monogenic knockout screens at stringent thresholds. Nineteen of 24 
(79%) synthetic lethal interactions were present in at least two out of three cell lines 
and 14 of 24 (58%) were present in all three cell lines tested, including alternate 
subunits of stable protein complexes as well as functionally redundant enzymes. 
Together these observations strongly suggest that paralogs represent a targetable set 
of genetic dependencies that are systematically under-represented among cell-
essential genes due to genetic buffering in monogenic CRISPR-based mammalian 
functional genomics approaches. 
 
4.2 Introduction 
The adaptation of CRISPR-Cas9 system to genome-wide knockout screens in 
mammalian cells has greatly transformed the search for cancer specific genomic 
vulnerabilities that can be targeted therapeutically. Monogenic pooled library CRISPR-
Cas9 knockout screens revealed that mammalian cells have as much as 3-4 times 
more essential genes than the previous RNAi technology was able to detect at the 
same false discovery rate (Hart et al., 2014). Moreover through immense monogenic 
screening efforts, multiple groups revealed lists of ~2000 highly concordant human 
essential genes, and comparison of CRISPR technology to orthogonal techniques 
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such as random insertion of gene traps also showed consistent results (Blomen et al., 
2015b; Hart et al., 2015; Wang et al., 2015).  
 
However, even with the CRISPR technology, the number of essential genes 
detected through these screens is still far less than the number of genes constitutively 
expressed in a given cell line. This phenomenon was previously observed in 
systematic gene knockout studies in S. cerevisiae (Giaever et al., 2002; Winzeler et 
al., 1999), where only 17% of yeast genes were essential for growth in rich medium 
(Winzeler et al., 1999). A closer look at the biological characteristics that define 
essentiality revealed a modular nature of gene essentiality (Hart et al., 2007) in which 
essentiality is not a characteristic of the protein or gene itself, but is rather defined by 
the protein complex to which the protein belongs. While genes that encode for 
members of a protein complex were shown to be more likely to be essential, 
paralogous genes were less likely to be essential (Gu et al., 2003).  However, a later 
study showed that a binary classification of genes into essential and non-essential 
was misleading due to the context-dependent nature of gene essentiality and that 97% 
of yeast genes showed some growth phenotype under different environmental 
conditions (Hillenmeyer et al., 2008). A similar study in C. elegans (Arun K. Ramani 
et al., 2012) suggested that virtually every gene is required for optimal growth in some 
condition. 
  
Paralogous genes arise from gene duplication events, which is a mechanism 
to create new genes. While gene duplication can result in two functionally distinct 
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genes over time, more frequently, the genes preserve a proportion of functional 
overlap through the process of subfunctionalization (Brookfield, 1997; Conant and 
Wolfe, 2008). In yeast gene deletion studies, singletons, which are genes without 
paralogs, were more than twice as likely as paralogous genes to be essential (Gu et 
al., 2003), indicating the role of paralogs in genetic buffering and suggesting that  that 
paralogs can affect how the yeast cells can respond to genetic perturbations. The 
buffering ability of paralogs to each other’s loss can be explained by their functional 
redundancy. Double deletion studies of paralog gene pairs in yeast revealed that 
synthetic lethality occurred with depletion of both paralog pairs, resulting in a fitness 
defect that was more than the expected additive effect of individual gene depletions 
(DeLuna et al., 2008). Further analyses determined sequence similarity of paralog 
pairs as a predictive characteristic for the level of functional redundancy (Li et al., 
2010). A major open question remains whether these findings hold true for human 
cells generally and cancer cells specifically.  
 
Recent studies investigated paralog dependencies in monogenic genome-wide 
CRISPR-Cas9 knockout screens in human cells, revealing differential effects of 
paralogs on cellular fitness. One study showed that paralogs are less likely to be 
essential in whole-genome CRISPR knockout fitness screens than singleton genes 
(De Kegel and Ryan, 2019), while another study demonstrated that paralogs that form 
heterodimers are more deleterious to the cell compared to non-heterodimer forming 
paralogs (Dandage and Landry, 2019). However, these studies did not take into 
account the effect of tissue-specific expression of the paralog pairs.  
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In this study, using publicly available genome wide screen data of genetically 
heterogeneous cell lines from the Cancer Dependency Map initiative (Meyers et al., 
2017; Tsherniak et al., 2017) we investigate paralogs among constitutively expressed 
never-essential genes as a set of targetable genetic dependencies that are 
systematically excluded in monogenic CRISPR-Cas9 knockout screening. We further 
demonstrate experimentally, using CRISPR-enCas12a multiplex knockouts, that dual-
gene screens reveal synthetic lethality among targeted paralogs. 
 
4.3 Results 
4.3.1 Why do we have so few essential genes in genome-wide 
CRISPR-Cas9 knockout screens? 
 
The question of what is missing from the monogenic knockout screens was 
based on an interesting observation we made during our analyses. Besides differential 
gene essentiality, the relationship between gene essentiality and gene expression 
patterns can also give important insights. Therefore, we first evaluated the gene 
expression patterns across hundreds of cell lines from the Cancer Cell Line 
Encyclopedia (CCLE) (Barretina et al., 2012). We took the mean and standard 
deviation of gene expression across 684 cell lines with high-quality CRISPR screens 
from the Avana 19Q4 data release (Broad DepMap, 2020c) and modeled the joint 
distribution with a linear combination Gaussian mixture models to perform an unbiased 
depiction of data. We ran the model with different numbers of components and 
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determined that the model with three components recapitulated the actual data the 









Figure 4.1. Gaussian mixture modeling (GMM) of gene expression of Avana 19Q4 cell 
lines. A) Scatter plot of standard deviation of expression versus mean expression of genes 
assayed in Avana library in Avana19Q4 cell lines. B) Contour plots of the two Gaussians 
from a two-component mixture model of data shown in A. C) Contour plots of three-
component GMM. D) Contour plots of four-component GMM. Figure adapted from Dede, 
M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect 
functional buffering among paralogs otherwise masked in monogenic Cas9 knockout 
screens. Genome biology, 21(1), 1-19. Copyright permissions are not required. This article 













Using the three-component GMM, we observed that the three groups 
corresponded to the three major populations in the data: constitutively expressed 
genes (high expression, low variance), never-expressed genes (low expression, low 
variance), and genes that show variable, sometimes tissue-specific gene expression 












Figure 4.2. Many constitutively expressed genes are never-essential in monogenic knockout 
screens. A) Scatter plot of mean versus standard deviation of log (TPM) gene expression in 
CCLE. Genes are color coded by components of a 3- element 2-d  Gaussian mixture model. 
B) Fraction of context, common and never-essentials as a function of gene expression profiles. 
Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a 
screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 
knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are not required. This 





Next, we evaluated the fraction of essential genes in each population. 
Consistent with our previous analyses, we defined essential genes as those with 
BAGEL-derived BF>10, which represents a high-confidence threshold corresponding 
to a posterior probability of essentiality of ~99%. When we look at the distributions, 
we can see that the majority of common essential genes that we defined in section 
2.3.5 are constitutively expressed as we would expect, while the context-dependent 
essential genes are divided across the constitutive expression and tissue-specific 
expression. Interestingly, among constitutively expressed genes, many are never 
essential in any CRISPR knockout fitness screen (3,032 of 7,282; 42%; Figure 4.2B). 
 
These observations regarding the constitutively expressed genes raised the 
question about why we observe so few essential genes in these genetically 
heterogenous screens. Based on work in previous studied in yeast and nematodes 
(Arun K. Ramani et al., 2012), we naively assumed that all constitutively expressed 
genes should be essential in at least some context, and hypothesized that some 
combination of environmental or genetic buffering masks the fitness consequences of 
individual gene knockouts. 
 
4.3.2 Knockout phenotypes of never-essential genes are being 
buffered by their paralogs 
 
A previous important study by De Kegel and Ryan observed that paralogs are 
less likely to be essential in whole-genome CRISPR knockout fitness screens than 
singletons (De Kegel and Ryan, 2019). This work discovered 226 cases where higher 
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essentiality in one paralog was accompanied by lower gene expression in the other, 
supporting the assertion that paralog buffering masks monogenic knockout fitness 
effects. We sought to extend this observation to include constitutively expressed 
genes. We obtained the list of the paralogs of human protein coding genes from 
Ensembl Biomart (Zerbino et al., 2017) along with protein sequence similarity 
information (see Methods). After filtering for constitutively expressed genes, we 
observed that paralogs show a wide range of amino acid sequence similarity, with the 
majority showing relatively low identity (Figure 4.3A). To evaluate whether paralogs 
are enriched in constitutively expressed never-essentials (hereafter “never-
essentials”), we adopted a sliding scale of sequence identity and measured, at each 
threshold, the fraction of never-essentials and the fraction of common essentials 
captured. As shown in Figure 4.3B, as sequence similarity stringency is relaxed, 
never-essentials are more likely to have a paralog than common essentials. At 35% 
or greater sequence similarity, nearly a third (27.9%) of constitutively expressed 
never-essentials have a paralog, compared with only 11.6% of common essentials 

















Figure 4.3. Never-essential genes are enriched in paralogs. A) Paralog pairwise amino-acid 
sequence identity among constitutively expressed paralogs. Green lines indicate 35% sequence 
similarity. B) Fraction of common essentials with a paralog versus the fraction of never-essentials 
with a paralog, colored by paralog sequence similarity. Green circle indicates 35% sequence 
similarity. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex 
enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic 
Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are not required. 





4.3.3 Computational detection of synthetic lethal paralog pairs 
 
The following work was done in collaboration with postdoctoral fellow lab 
member Eiru Kim, Ph.D.  
To identify functionally redundant paralogs, we explored the Avana and Sanger 
data to find cases where loss of function of one member of a paralog pair resulted in 
increased dependency on the other (Figure 4.4A). We limited the search for functional 
redundancy to genes classified as constitutively expressed according to our model, 
which excludes false associations arising from tissue-specific expression of paralog 
family members. The search is further constrained by requiring that one member of 
the pair show loss of function, either through predicted deleterious mutation or by 
severe decrease in gene expression (see Methods), in a sufficient number of cell lines 
to result in a statistically significant difference in gene essentiality of the other member. 
By applying this test to 628 gene pairs in the Avana data and 432 gene pairs in Project 
Score (Figure 4.4A), we detected a total of 66 such cases of putative functional 

















In our results, two well-described cases in the BAF (mammalian SWI/SNF) complex 
were immediately apparent: mutations in SMARCA4 are strongly associated with 
dependency on paralog SMARCA2 (P<10-10; Figure 4.5A), and mutations in ARID1A 
are associated with ARID1B dependency (P<10-9; Figure 4.5B). Expanding loss-of-
Figure 4.4. Computational detection of constitutively-expressed paralog buffering. A) 
Overview of computational methodology: loss of function in one member of a paralog pairs 
gives rise to gene essentiality in the other member. The bar chart indicates the number of 
pairs testable by this method. B) Summary of the results by the Broad dataset and Sanger 
dataset. C) Overlap of computationally derived synthetic lethal hits between the Sanger 
(Project Score) and Broad (DepMap/Avana) datasets. Figure made by Eiru Kim, Ph.D., used 
with permission. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). 
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in 
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are 




function to include significantly depleted gene expression also reveals an emergent 
dependency on RPP25L when RPP25 is depleted (P<10-52; Figure 4.5C). The two 
genes encode redundant subunits of RNAse P, a ribonuclease critical for maturation 
of tRNA, whose functional buffering was previously observed (Wang et al., 2015). A 
fourth example is FAM50A/FAM50B putative functional redundancy (Figure 4.5D). 





Unfortunately, with this analysis we were not able to identify a lot of synthetic lethal 
paralog pairs, since the cell lines screened by CRISPR knockout libraries only contain 
LOF alleles of a fraction of the candidate paralogs, limiting this discovery avenue to a 
few dozen pairs. The aforementioned paralog study also identified computationally 
identified paralog synthetic lethals. Therefore, we compared our hits with the hits in 
De Kegel and Ryan study (De Kegel and Ryan, 2019), and showed that more than 
half of our computationally derived hits (39 of 66, 59%;Figure 4.6) are present in their 
study, indicating strong concordance between the two approaches. Nevertheless, we 
observed a large number of hits unique to each approach, clearly indicating that 
neither approach is saturating, and additional methods, both computational and 
experimental, are required to discover the complete set of paralog synthetic lethal 
interactions. 
 
Figure 4.5. Computationally detected synthetic lethal paralog pairs. A-D) Scatter. Plots of 
Bayes Factors of paralog pairs, with labels indicating loss of function (LOF) and corresponding 
p-values. Figure made by Eiru Kim, Ph.D., used with permission. Figure adapted from Dede, 
M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional 
buffering among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome 
biology, 21(1), 1-19. Copyright permissions are not required. This article is available under a 




Figure 4.6. Comparison of computationally derived hits from our analysis with hits in De Kegel 
and Ryan et al study. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. 
(2020). Multiplex enCas12a screens detect functional buffering among paralogs otherwise 
masked in monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright 
permissions are not required. This article is available under a Creative Commons International 
License – https://creativecommons.org/licenses/by/4.0/. 
 
4.3.4 Discussion and conclusions 
 
CRISPR technology has revolutionized mammalian functional genomics and cancer 
targeting by leveraging endogenous DNA repair machinery to generate gene 
knockouts on a genomic scale. Extensive screening of cancer cell lines has been 
performed under the DepMap and Project Score initiatives to identify context-specific 
weaknesses and cancer biomarkers. Analyses of this data have revealed activation 
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of oncogenic pathways and oncogene dependencies (Tsherniak et al., 2017) as well 
as biomarker type dependencies such as Werner helicase, WRN, in colorectal and 
ovarian cell lines with MSI (Behan et al., 2019; Chan et al., 2019). However, despite 
these efforts, questions about what might be systematically missing from these data 
have, to our knowledge, not been rigorously explored. 
 
We note that there are about 7,000 genes that are constitutively expressed in each 
cell, but only about half of these are ever detected as essential. Studies in model 
organisms suggest that virtually every gene shows a growth phenotype under some 
environmental condition (Hillenmeyer et al., 2008; Arun K. Ramani et al., 2012). It is 
unknown whether this holds true for individual mammalian cells, though tumors are 
often modeled as though they are colonies of single-celled organisms. It is also the 
case that most genetic screens of tumor cells are carried out under permissive growth 
conditions, minimizing nutrient and oxidative stress to maximize growth rate and 
improve detection of dropouts. Thus, the degree of environmental buffering is largely 
unknown for these constitutively expressed never-essentials.  
 
However, these never-essentials are highly enriched for paralogs. They are ~3 times 
more likely to have a paralog than always-essentials, suggesting that functional 
redundancy by related genes masks detection of a substantial population of genes in 
monogenic CRISPR knockout screens. This has profound implications for efforts to 
match targeted drugs with tumor genotypes, and to discover new candidate drug 
targets. Targeted small molecules often don’t discriminate, or discriminate poorly, 
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between closely related paralogs, and it is often their promiscuity rather than their 
specificity that renders them effective. For example, MEK inhibitor trametinib 
effectively targets the protein products of both MAP2K1 and MAP2K2, redundant 
kinases downstream of RAS/RAF oncogenes, but the functional redundancy of these 
genes renders them both invisible to monogenic CRISPR screens, even in RAS/RAF 
backgrounds (Kim et al., 2019).  
 
Recent developments in CRISPR screening technology enable effective genetic 
targeting of multiple genes simultaneously. Cas12a, previously known as Cpf1, is able 
to process a polycistronic mRNA to generate multiple CRISPR RNAs (crRNAs). This 
makes multiplexing much easier compared to inefficient Cas9 based multiplex 
systems which requires each guide RNA to be expressed by its own promoter. The 
improved version of this enzyme, enCas12a (Kleinstiver et al., 2019), coupled with an 
effective guide design algorithm (DeWeirdt et al., 2020) presents a powerful platform 
for multiplex genetic perturbation. Multiplex guide libraries can be synthesized directly, 
without requiring additional targeted or random mixing cloning steps, allowing direct 
assay of specific gene pairs as described here with roughly the same level of effort as 
a now-standard Cas9 monogenic screen. The robustness of predicted guide cutting 
efficiency remains untested relative to Cas9, given the relatively small amount of 
enCas12a data available, suggesting adopters of this technology should err toward 
caution when deciding on parameters for new experiments (e.g. number of guides per 
gene, number of gene-vs-control guide pairs). Nevertheless, as we demonstrate here, 
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this platform holds enormous potential for exploring the stability and plasticity of 




4.3.5 Dual gene CRISPR knockout screening with enCas12a and 
identification of synthetic lethal paralog pairs 
 
The following work was done in collaboration with experimental team member 
Megan McLaughlin who performed the experimental work and Traver Hart, Ph.D .  
 
Considering the limitations of our computational method to detect paralog 
synthetic lethal pairs, we sought to expand our knowledge of paralog buffering through 
systematic experimental dual-gene CRISPR knockout screening. We decided to 
utilize the Cas12a enzyme, formerly known asCpf1, to conduct our experiments with 
our CRISPR-Cas12a system which has some important differences compared to 
Cas9. Cas9 requires a G-rich protospacer adjacent motif (PAM) sequence, while 
Cas12a prefers a T-rich PAM (Zetsche et al., 2015). The two enzymes also differ in 
location and type of cuts they make. Cas9 causes a double stranded break at the PAM 
proximal end of the sgRNA with a blunt cut. However, Cas12a cuts at the PAM distal 
end of the sgRNA with a staggered cut (Zetsche et al., 2015). Another key difference 
is between the constant regions of these two enzymes. Cas9 has a 76 nucleotide 
constant region called the tracrRNA while Cas12a has a 20 nucleotide constant region 
which we refer to as the direct repeat. However, the most important reason for why 
we are interested in Cas12a is that it enables multiplexing since it has an endogenous 
RNA endonuclease function that enables processing and utilization of multiple gRNA 
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from a single polycistronic transcript (Zetsche et al., 2015).  This is in contrast to Cas9 







Moreover, the modified version of this enzyme, enCas12a, offers superior 
performance in genetic screens in mammalian cells (DeWeirdt et al., 2020; Kleinstiver 
et al., 2019). A key advantage of this system is that specific guide pairs can be 
synthesized in a single oligonucleotide, allowing one-step library design, which offers 
a major advantage over multiplex Cas9 systems (Chen et al., 2015; Cong et al., 2013; 
Kabadi et al., 2014; Shen et al., 2017). We therefore sought to apply the enCas12a 
multiplex knockout system to systematically identify paralog synthetic lethals.  
 
We first identified 400 candidate paralog pairs to test design a 12K library. 
These gene pairs were algorithmically selected based on several criteria, including 
amino acid sequence similarity, mRNA expression and co-expression, and whether 
either gene is frequently essential in DepMap. We manually added five additional 
candidate gene pairs from the literature: SMARCA2-SMARCA4, CHD1-CHD3, ME2-
Cas12a 
Figure 4.7. Cas12a requires only one promoter to drive expression of multiple guides in 
contrast to Cas9 based systems. 
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ME3, BCL2L1-MCL1, and BRCA1-PARP1, for a total of 405 targeted gene pairs. For 
each gene, up to three CRISPR RNA (crRNA) were selected using guides  designed 
by DeWeirdt et al (DeWeirdt et al., 2020). Each gene pair was targeted with all 9 
combinations of guides, in both A-B and B-A orientations, for a total of 18 clones 
targeting each pair. To evaluate single-knockout phenotype, we paired gene-targeted 
crRNA with three guides drawn from a pool of guides targeting 50 nonessential genes 
(Figure 4.8A). We additionally targeted 50 essential genes, paired with random 






We transduced the library into enCas12a-expressing cells from three cancer 
cell lines of diverse origins: A549, a KRAS-driven lung cancer cell line; HT29, a BRAF-
mutant colorectal cancer cell line, and OVCAR8 ovarian cancer cells. Cells were 
passaged in three replicates for 10 doublings and the relative abundance of each dual-
Figure 4.8. Multiplex gene knockout with enCas12a. A) Experimental design. EnCas12a 
crRNA dual-guide array design. Each construct targets two genes; each gene is targeted by 3 
crRNA; each candidate paralog gene pair is targeted by 18 gene-gene constructs, with six 
gene-control constructs per gene (including both A-B and B-A orientations.  B) Quality control 
plot showing the separation of SMF of constructs targeting control essential and nonessential 
genes. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex 
enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic 
Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are not required. 




guide construct was measured by 75-base single end sequencing of the target 
amplicon, with fold changes measured relative to abundance in the plasmid pool.  
 
Quality control steps including abundance and distribution of read counts, 
clustering of raw read counts and fold changes, and separation of essential and 
nonessential control genes indicated effective screen performance (Figure 4.8B). 
Additionally, high correlation of A-B and B-A guide pairs (Figure 4.9A) indicate 
negligible positional bias in the enCas12a guide arrays. We therefore included both 





To calculate genetic interaction/synthetic lethality, we measured the single 
mutant fitness (SMF) for each gene as the mean fold change of the gene-control 
constructs. For control essential genes, SMF in our enCas12a screen correlates with 
BAGEL-derived Bayes Factor scores for the DepMap screens in the same cell lines 
(Figure 4.9B). We then calculated the observed double mutant fitness (DMF) as the 
mean log fold change of the dual-gene knockout constructs (18 constructs per gene 
pair), and compared it to the expected DMF, the sum (in log space) of each gene’s 
SMF to obtain delta log fold changes (dLFCs) (Figure 4.10A). To be able to make 
comparisons across screens, we converted these dLFCs to z-delta log fold changes 
(zdLFC), by truncating the top and bottom 2.5% of dLFC scores.  As has been widely 
observed in genetic interaction screens, most digenic knockouts do not result in an 
unexpected phenotype; here we observe that the distribution of zdLFC values has 
most of its mass around zero (no synthetic effect), with a long tail of negative (synthetic 
sick/lethal) zdLFC scores (Figure 4.10B). 
Figure 4.9. enCas12a screen shows negligible position effects and displays correlation 
between SMF and Bayes Factors. A) Scatter plot of all mirror constructs (same crRNA in A-B 
and B-A orientations) showing lack of positional effects. B) SMF in A549 screen versus gene 
BF in Avana data. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). 
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in 
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are 







Figure 4.10. Synthetic lethality and distribution of zdLFCs in paralog screen.  A) Evaluating 
synthetic lethality. Single mutant fitness (SMF) is the mean log fold change of control guides 
targeting a single gene. Expected double mutant  fitness (DMF) is the sum of SMFs. Observed 
DMF is the mean log fold change of dual-targeting constructs. Delta log fold change (dLFC) is 
the difference between observed  and expected log fold change. B) The distribution of z-
transformed dLFCs of paralog pairs in the three cell lines tested.Figure adapted from Dede, 
M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional 
buffering among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome 
biology, 21(1), 1-19. Copyright permissions are not required. This article is available under a 




At a zdLFC score < -3, all three screens showed high concordance, with 19 of 
24 (79%) synthetic lethals present in at least two out of three cell lines and 14 of 24 
(58%) present in all three (Figure 4.11A,B). We utilized the OHNOLOGS v2.0 
database, which is a repository of genes arising from whole genome duplications 
(Singh et al., 2015) to evaluate if there is an enrichment among ohnologs. We 
observed that fifteen of the 24 hits (62.5%) are ohnologs, gene copies resulting from 
whole-genome duplication (Singh et al., 2015), compared to 246 of the 405 gene pairs 
tested in our study (60.7%), indicating neither enrichment nor depletion of synthetic 






A previous study indicated that simple difference in log fold change is not an 
effective measure of evaluating genetic interactions and the authors offered a more 
detailed approach to calculate such interactions . Therefore we evaluated the 
concordance of our zdLFC scores with the GEMINI scores and found that our zdLFCs 
are highly correlated with GEMINI (Zamanighomi et al., 2019), with R2 values ranging 
from 0.59 (A549) to 0.74 (OVCAR8), and the two methods offer essentially no 
difference in hit calls (Figure 4.12). 
Figure 4.11. Synthetic lethal paralog pairs. A) Overlap of 24 synthetic lethal paralog hits 
with zdLFC < -3 in any of the three cell lines. B) Heatmap showing the zdLFC scores for the 
24 hits in the three cell lines. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & 
Hart, T. (2020). Multiplex enCas12a screens detect functional buffering among paralogs 
otherwise masked in monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. 
Copyright permissions are not required. This article is available under a Creative Commons 





Figure 4.12. Comparison of zdLFC scores to scores generated by GEMINI. A) zdLFC vs 
GEMINI scores for 24 synthetic lethal pairs with their respective correlation coefficients. B) 
zdLFC vs GEMINI scores for all tested paralog pairs with their respective correlation 
coefficients. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). 
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in 
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are 




A closer look at the many top-scoring hits indicates strong concordance with 
other data corroborating a functional buffering/synthetic lethal relationship. RNA 
helicases DDX19A and DDX19B show characteristics of synthetic lethality as 
described by De Kegel and Ryan (De Kegel and Ryan, 2019) across DepMap cell 
lines, DDX19A is strongly essential only when DDX19B is expressed at low levels 
(Figure 4.13).  
 
 
Figure 4.13. DDX19A gene essentiality (BF) vs. DDX19B gene expression (logTPM) in Avana 
data. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex 
enCas12a screens detect functional buffering among paralogs otherwise masked in 
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are 
not required. This article is available under a Creative Commons International License – 
https://creativecommons.org/licenses/by/4.0/. 
 
Similarly, TIAL1 low expression is associated with TIA1 increased essentiality Figure 
4.11B. HDAC1/HDAC2 and MAPK1/MAPK3 paralog pairs also displayed strong 
synthetic lethality across the cell lines we tested (Figure 4.11B). Genes CNOT7 and 
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CNOT8 encode alternate subunits of the CCR4-NOT complex, a critical regulator of 
eukaryotic gene expression (Lau et al., 2009). Other subunits are sporadically 
essential in our three cell lines (Figure 4.14A) but frequently essential across DepMap 
data, consistent with a constitutively essential protein complex. Moreover, CNOT7 
essentiality is weakly but significantly anticorrelated with CNOT8 mRNA expression 
(Pearson correlation coefficient -0.21, P<10-6). Likewise, COPS7A and COPS7B 
encode alternate, replaceable subunits of the COP9 signalosome complex; other 



























Strikingly, we observed that synthetic lethality, even among paralogs, can also 
be context-dependent. Cyclin paralogs are often redundant interaction partners with 
their cognate cyclin-dependent kinases; here, CCNE1 and CCNE2 are synthetic lethal 
where CDK2 is highly essential, especially in OVCAR8 cells (Figure 4.14C). Similarly, 
CCNT1-CCNT2 show weaker but significant synthetic lethality (zdLFC < -2.5 in A549 
and < -1 in the other two cell lines) while their binding partner, CDK9, is highly essential 
in all three (Figure 4.14D).  
Though the synthetic lethal relationships between SWI/SNF complex members 
ARID1A/ARID1B and SMARCA2/SMARCA4 are well described in the literature and 
are detected in large scale screening data, their synthetic lethality only occurs where 
Figure 4.14. Selected co-complex interactions of synthetic lethal paralog pairs. A) 
CNOT complex showing the synthetic lethality of the CNOT7/CNOT8 paralog pair, 
with other members sporadically essential in the three cell lines tested. B) Members of 
the essential COP9 signalosome complex show uniform essentiality across the tested 
cell lines except the COPS7A/COPS7B which displays paralog synthetic lethality.  C) 
CCNE1/CCNE2 shows synthetic lethality especially in OVCAR8 cells, where their cognate 
cyclin dependent kinase CDK2 shows strong essentiality. D) Similar to C, CCNT1/CCNT2 
are synthetic lethal where CDK9 is essential. Figure adapted from Dede, M., McLaughlin, 
M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional buffering 
among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome 
biology, 21(1), 1-19. Copyright permissions are not required. This article is available under 
a Creative Commons International License – https://creativecommons.org/licenses/by/4.0/. 
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the SWI/SNF complex is itself essential. We test four paralog pairs in the BAF 
complex: ARID1A/ARID1B, SMARCA2/SMARCA4, SMARCC1/SMARCC2, and 
SMARCD1/SMARCD2, but we detect no synthetic lethal interactions, most likely 
because the complex itself is not essential in the cell lines we tested.  
Synthetic lethality between our hits is corroborated by a dual-gene knockout 
screen using the CHyMErA hybrid Cas12/Cas9 system (Gonatopoulos-Pournatzis et 
al., 2020). The 678 paralog pairs evaluated in the CHyMErA screens contain 110 pairs 
targeted in our library, including 12 of the 24 hits we defined. Our results are generally 
consistent, with TIA1/TIAL1, SAR1A/SAR1B, PITNA/PITNB, and CNOT7/CNOT8 
scoring strongly in both assays Figure 4.15A-B). In contrast, MAPK1/MAPK3 and 
CCNE1/CCNE2 are only hits in our cell lines. As with gene essentiality, synthetic 






4.4 Discussion and conclusions 
CRISPR technology has revolutionized mammalian functional genomics and 
cancer targeting by leveraging endogenous DNA repair machinery to generate gene 
knockouts on a genomic scale. Extensive screening of cancer cell lines has been 
performed under the DepMap and Project Score initiatives to identify context-specific 
weaknesses and cancer biomarkers. Analyses of this data have revealed activation 
of oncogenic pathways and oncogene dependencies (Tsherniak et al., 2017) as well 
as biomarker type dependencies such as Werner helicase, WRN, in colorectal and 
ovarian cell lines with MSI (Behan et al., 2019; Chan et al., 2019). However, despite 
these efforts, questions about what might be systematically missing from these data 
have, to our knowledge, not been rigorously explored. 
Figure 4.15. Comparison of common paralog pairs tested in our enCas12a screen with 
the hybrid Cas9/Cas12a CHyMErA screens. A) Comparison of the 12 enCas12a hits in 
this study that were screened in HAP1 in cell line in the CHymErA study. B) Comparison 
of all 110 paralog pairs tested in both enCas12a screen and the HAP1 CHymErA screen. 
Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex 
enCas12a screens detect functional buffering among paralogs otherwise masked in 
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions 
are not required. This article is available under a Creative Commons 
International License – https://creativecommons.org/licenses/by/4.0/. 
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We note that there are about 7,000 genes that are constitutively expressed in 
each cell, but only about half of these are ever detected as essential. Studies in model 
organisms suggest that virtually every gene shows a growth phenotype under some 
environmental condition (Hillenmeyer et al., 2008; Arun K. Ramani et al., 2012). It is 
unknown whether this holds true for individual mammalian cells, though tumors are 
often modeled as though they are colonies of single-celled organisms. It is also the 
case that most genetic screens of tumor cells are carried out under permissive growth 
conditions, minimizing nutrient and oxidative stress to maximize growth rate and 
improve detection of dropouts. Thus, the degree of environmental buffering is largely 
unknown for these constitutively expressed never-essentials.  
 
However, these never-essentials are highly enriched for paralogs. They are ~3 
times more likely to have a paralog than always-essentials, suggesting that functional 
redundancy by related genes masks detection of a substantial population of genes in 
monogenic CRISPR knockout screens. This has profound implications for efforts to 
match targeted drugs with tumor genotypes, and to discover new candidate drug 
targets. Targeted small molecules often don’t discriminate, or discriminate poorly, 
between closely related paralogs, and it is often their promiscuity rather than their 
specificity that renders them effective. For example, MEK inhibitor trametinib 
effectively targets the protein products of both MAP2K1 and MAP2K2, redundant 
kinases downstream of RAS/RAF oncogenes, but the functional redundancy of these 
genes renders them both invisible to monogenic CRISPR screens, even in RAS/RAF 
backgrounds (Kim et al., 2019).  
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Recent developments in CRISPR screening technology enable effective 
genetic targeting of multiple genes simultaneously. Cas12a, previously known as 
Cpf1, is able to process a polycistronic mRNA to generate multiple CRISPR RNAs 
(crRNAs). This makes multiplexing much easier compared to inefficient Cas9 based 
multiplex systems which requires each guide RNA to be expressed by its own 
promoter. The improved version of this enzyme, enCas12a (Kleinstiver et al., 2019), 
coupled with an effective guide design algorithm (DeWeirdt et al., 2020) presents a 
powerful platform for multiplex genetic perturbation. Multiplex guide libraries can be 
synthesized directly, without requiring additional targeted or random mixing cloning 
steps, allowing direct assay of specific gene pairs as described here with roughly the 
same level of effort as a now-standard Cas9 monogenic screen. The robustness of 
predicted guide cutting efficiency remains untested relative to Cas9, given the 
relatively small amount of enCas12a data available, suggesting adopters of this 
technology should err toward caution when deciding on parameters for new 
experiments (e.g. number of guides per gene, number of gene-vs-control guide pairs). 
Nevertheless, as we demonstrate here, this platform holds enormous potential for 





4.5.1 Pre-processing of DepMap essentiality data 
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A raw read count file of CRISPR pooled library screens for 690 cell lines using 
Avana library (Meyers et al., 2017) (Broad DepMap project 19Q4) was downloaded 
from the data depository (https://depmap.org/portal/). Also, we downloaded Project 
Score (Sanger) screen (Behan et al., 2019) raw read counts for 323 cancer cells from 
the data depository (https://score.depmap.sanger.ac.uk/). We filtered the dataset to 
keep only the protein-coding genes for further analysis and updated their names using 
HGNC (DeLuna et al., 2008) and CCDS (Farrell et al., 2014) database. We discarded 
sgRNAs targeting multiple genes in Avana library to avoid genetic interaction effects. 
The raw read counts were processed with the CRISPRcleanR (Iorio et al., 2018) 
algorithm to correct for gene-independent fitness effects and calculate fold change. 
After that, the CRISPRcleanR processed fold changes of each cell line were analyzed 
through updated BAGEL2 build 114 (https://github.com/hart-lab/bagel). In comparison 
with published BAGEL version v0.92 (Hart and Moffat, 2016), the updated version 
employed a linear regression model to interpolate outliers and 10-fold cross validation 
for data sampling. Essentiality of genes was measured as Bayes Factor (BF) based 
on gold standard reference sets of 681 core essential genes and 927 nonessential 
genes (Hart et al., 2017, 2014). Positive BF indicates essential genes and negative 
BF indicates non-essential genes. Lists of core essential genes and nonessential 
genes used in this study have been uploaded on the same repository with BAGEL2 
software. To correct unexpected essentiality by sgRNAs targeting non-protein coding 
regions in addition to desired target protein coding gene, the multi-targeting effect of 
sgRNAs has been corrected using BAGEL2 -m option. The screen quality was 
evaluated by using “precision-recall” function in BAGEL2 software, and F-measure, 
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the harmonic mean of precision and recall, was calculated for each screen at BF=5. 
Finally, 581 cell lines for Broad screen and 320 cells for Sanger screen were selected 




4.5.2 Defining constitutively expressed genes with Gaussian 
Mixture Models 
 
We utilized the log2 transformed RNA-seq TPM expression data from DepMap 
Data Portal expression data for Avana19Q4 release for 684 cell lines (Meyers et al., 
2017; Tsherniak et al., 2017). The standard deviation of expression versus the mean 
expression values for all genes assayed in the Avana library (N=17,755) across all 
cell lines, for which the expression data was available, were plotted. Python 3.6.9 
package sklearn and its GaussianMixture function was used to classify genes by 
Gaussian mixture modeling based on mean and standard deviation of mRNA 
expression. A three-component model was selected as the best fit to the data (Figure 
4.1) since the addition of a fourth component resulted in two highly overlapping 
component distributions. The group with the least expression and low standard 
deviation was labeled as never expressed, the second group with very high standard 
deviation and a range of mean expression values was labelled as sometimes 
expressed and the constitutively expressed group with high mean expression and low 
standard deviation was classified as constitutively expressed genes. With this 
classification, we identified 7,282 always expressed, 4,544 never expressed and 
5,929 sometimes expressed genes in the Avana dataset.  
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4.5.3 Identification of the set of paralogs to be tested 
 
To identify and predict paralog pairs which we hypothesized to be enriched in 
synthetic lethal interactions, we obtained the paralogs of all human protein coding 
genes from Ensembl Biomart (Zerbino et al., 2017). Next, we applied multiple filters 
on various features of these paralog pairs including percent sequence similarity, mean 
expression, standard deviation of expression, co-expression and gene essentiality 
profiles across all cell lines. We then built a network of paralogous gene families using 
Cytoscape (Shannon, 2003) and filtered them initially for protein sequence similarity 
greater than or equal to 45%, mean expression (logTPM) >1.5, standard deviation of 
expression <1.25, co-expression Pearson correlation coefficient >0.1. Finally, we 
removed genes that were essential in more than 30 cell lines in order to eliminate 
essential pairs, resulting in a set of 400 pairs. In addition, we manually added several 
candidate synthetic lethals from previous literature, including SMARCA2/SMARCA4, 
CDH1/CHD3, ME2/ME3, BCL2L1/MCL1, and BRCA1/PARP1 to get a total of 405 
pairs in our study`. 
 
4.5.4 Computational discovery of functional redundancy between 
paralogs in DepMap and Sanger Screens 
 
To investigate evidence for the functional redundancy between paralogous 
genes in Broad and Sanger screens, we tested whether a gene is essential when its 
paralog partner exhibits a loss of function phenotype. Firstly, we defined loss of 
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function (LOF) as either the presence of a damaging mutation calls (we considered 
both frameshift or nonsense mutations) adopted from CCLE mutation data (Ghandi et 
al., 2019) or depletion of expression (mean log TPM < 1.0, CCLE RNA-seq) or 
presence of deletion (copy number < 0.1, CCLE Copy number data). Next, we 
conducted a statistical test of synthetic essentiality which is defined when a gene is 
observed as essential when its paralog partner loses its function. We filtered all protein 
coding paralog pairs to obtain only one to one paralog pairs with at least 30% 
sequence similarity for our analysis in order to maximize the number of paralog pairs 
to conduct our statistical tests. Furthermore, we only considered pairs which have at 
least two LOF calls and are essential in at least two cell lines. P-value was calculated 
by the one-sided Fisher’s exact test on the 2x2 contingency table of the number of 
cells classified by LOF and essential (BF > 10), and false discovery rate (FDR) was 
calculated by the method of Benjamini & Hochberg. We addressed pairs bidirectional 
ways, which test a significance of essentiality of gene A upon LOF of gene B and vice 
versa. A total of 58 pairs among 628 tested pairs in the Broad dataset and 40 pairs 
among 432 tested pairs in the Sanger dataset passed a threshold of P-value < 0.01. 
Thirty-two pairs were common to both datasets. 
 
4.5.5 Library design for enCas12a screen 
 
We selected Cas12a CRISPR RNA sequences from a library from (DeWeirdt 
et al., 2020). Guides were selected from an AsCas12a library design from July 2019, 
representing an intermediate phase of development of the DeWeirdt et al work. Up to 
the top three guide sequences were selected from the library for each of the 793 
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candidate paralog genes (405 gene pairs), but given the restrictive TTTV PAM 
sequence for AsCas12a, three guides were not available for every gene. For two 
genes (ABHD16B, DGCR6), no crRNA were present in the library; pairs including 
these genes were removed in the downstream analysis. As controls, a set of 50 
nonessential and 50 pan-essential genes were chosen; genes were filtered for those 
with 1:1 orthologs in both rat and mouse to provide a useful multi-species reference 
set. These control genes are listed in Additional file 5: Table S4 of our published 
manuscript (Dede et al., 2020a). 
 
To design the library, we first pooled all crRNA targeting nonessential control 
genes (141 crRNA targeting 50 genes). Then, for each paralog gene pair, we collected 
all crRNA pairs in both orientations – for n=3 crRNA per gene, there are n2= 9 crRNA 
pairs, or 18 total clones (A-B and B-A orientations for each). To generate single-
knockout controls, we then took each crRNA targeting one of the paralogs and paired 
it with a crRNA randomly drawn from the nonessential pool, again designing clones in 
both A-B and B-A orientations, for a total of six control constructs per experimental 
gene (where n=3 crRNA/gene). Finally, we took our set of control essential genes 
(n=149 crRNA targeting 50 genes) and randomly paired each guide with a 
nonessential guide, in both orientations, as described above, for a total of 298 positive 
control guide constructs. The final library targets 841 genes (889 including 
nonessential genes) and 403 specified gene pairs with 12,328 constructs. 
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4.5.6 Screen analysis 
Construct sequences were combined into FASTA format (“paralog_2mer.fa”) 
and indexed with bowtie-build, and sequencing reads were mapped to this database 
with bowtie (Langmead et al., 2009) with the following command line parameters (trim 
ten 3’ bases, allow 3 mismatches, discard sequences which map to more than one 
reference sequence): 
bowtie --trim3 10 -v 3 -m 1 -S --sam-nohead paralog_2mer 
[fastq_files] > [output.sam] 
Sequence mapping rates ranged from 37-58%, averaging ~47%. Using this 
strict single-read mapping approach guarantees that only high-quality guide 
constructs were evaluated. Read counts were combined into a single matrix for further 
analysis. 
Subsequent analysis was executed in Python notebooks, all of which are available at 
https://figshare.com/articles/software/enCas12a_screen_analysis_pipeline/1227564
2 (Dede et al., 2020b). Mean read depth for all samples exceeded 500 reads/guide, 
and all samples showed read distributions with minimal skew. A pseudocount of 5 
reads was added to each construct in each sample, then read counts per sample were 
normalized to an average of 500 reads/guide (6.2M reads/sample), and log fold 
change for each guide was calculated relative to the plasmid sequence counts 
(notebook cas12a-step01-screen_QC). Screen replicate quality was verified by 
plotting the kernel density estimate of the fold changes of all control essential 
constructs vs. all other constructs (see notebook cas12a-step04_calc_SMF). Screen-




Single mutant/knockout fitness, SMF, for each gene was calculated as the 
mean construct fold change of gene-control constructs, for both A and B position. 
Construct-level consistency is shown in Figure 4.9A but gene level SMF is even more 
consistent (see notebook cas12a-step04_calc_SMF), with Pearson correlation 
coefficients ranging from 0.87 to 0.94. A-B and B-A constructs were subsequently 
averaged to calculate sample-level SMF for each gene. The distribution of each shows 




Cell line Mean SMF Median SMF 
A549 -0.10 0.014 
HT29 -0.10 0.053 
OVCAR8 -0.10 0.082 
 
Table 2. Mean and Median SMF in three screens. Table adapted from Dede, M., McLaughlin, 
M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional buffering among 
paralogs otherwise masked in monogenic Cas9 knockout screens. Genome biology, 21(1), 1-
19. Copyright permissions are not required. This article is available under a Creative 
Commons International License – https://creativecommons.org/licenses/by/4.0/. 
 
Difference in log fold change for a gene pair (dLFC) was calculated as observation, 
the mean LFC of all constructs targeting the gene pair, minus expectation, the sum of 
the SMF for the two genes. Given the skew of the SMF distributions, gene pairs with 
small positive SMF values sum yield an expectation of a positive LFC and, therefore, 
negative dLFC scores when the observed LFC is near zero. This explains the slight 
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negative offset of dLFC distributions and necessitates normalization before calling 
hits. We normalized by Z-transformation after removing the top and bottom 2.5% of 
scores (see notebook cas12a-step07_robustZ_of_dLFC). The resulting zdLFC table 



































Chapter 5:  General discussion and final remarks 
 
“A man cannot become a competent surgeon without the full knowledge of 
human anatomy and physiology, and the physician without physiology and 
chemistry flounders along in an aimless fashion, never able to gain any 
accurate conception of disease, practicing a sort of popgun pharmacy, hitting 
now the malady and again the patient, he himself not knowing which.” 
  Sir William Osler (1849–1919) 
During my years as a medical student and as a physician, I have taken Sir 
William Osler’s above quote to heart while seeing patients.  I was trained to 
understand that the basis of medicine relies upon understanding the mechanisms 
behind how the disease operates and affects the physiology of the patient. If we think 
about the human body as a big system, when something goes wrong in the body - 
whether it is due to an outside stimulus such as a bacterial infection or something 
sporadic like a mutation- it triggers a series of reactions by which the body responds 
through symptoms. As clinicians, we observe these signs carefully and using our 
knowledge on the normal human body structure and function, we try to identify the 
best treatment. Unfortunately, I experienced that the traditional approach to treating 
cancer has been an example of the “popgun pharmacy” that Sir Osler mentions. The 
treatment regimen for cancer usually involves a series of aimless combination of drugs 
and invasive procedures without an understanding of the entire human body as an 
inter-connected network of systems. Giving toxic doses of radiation to kill cancer cells, 
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knowing very well that the procedure itself is harmful to the body is an example of the 
desperate actions the clinicians have chosen to take. These approaches are in 
complete contrast to how we are trained to “treat the patient and not the disease”.  
 
Fortunately, with the developments in systems biology and functional 
genomics, we do not have to adhere to these repeatedly failing “treatment” 
methodologies where we only address the symptoms. Now, we have an opportunity 
to go back to the basics and understand the molecular basis of cancer which will help 
us view this disease as a systemic disorder. Beginning with understanding the 
structure and function of genes, the interaction networks of gene products, hierarchical 
organization of networks in a cell, then expanding our knowledge to the networks of 
cells, and to organ systems is the key towards unravelling how cancer dysregulates 
and rewires individual components in our body, creating systemic effects. The 
complete sequencing of the human genome paved the way towards this goal, 
demonstrating the need to identify the function of every gene in the human genome. 
With advances in next generation sequencing, projects such as The Cancer Genome 
Atlas (TCGA) enabled the molecular profiling of tumor samples from thousands or 
cancer patients. These efforts yielded a previously unimaginable amount of data as 
well as targeted cancer therapeutics with minimal side effects. However, although 
genomic characterization helped us identify cancer specific mutations and genomic 
expression profiles, the functional significance of these abnormalities have been 
challenging to decipher only from genomic data. The net result is that only a fraction 
of cancer patients can benefit from the perks of precision medicine since we are still 
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a long way from analyzing every individual patients’ tumor for unique vulnerabilities 
and predicting which drug would have the most favorable outcome. 
 
Recent developments in functional genomics and high throughput CRISPR 
technologies have enabled genome-scale perturbations to measure and quantify 
cause and effect relationships. These efforts are crucial for studying gene function as 
well as for determining cellular dependencies. Using data from genome-wide CRISPR 
knockout screens, we can identify tumor-specific essential genes which represent 
potential therapeutic targets. With large scale projects such as the Cancer 
Dependency Map initiatives by the Broad and Sanger Institutes (Behan et al., 2019; 
Tsherniak et al., 2017), we have extensive data to systematically investigate cancer 
specific vulnerabilities.  
 
In this dissertation, I described my efforts to advance our understanding of 
essential genes in human cancer cell lines. I conducted a series of systematic 
analyses in order to investigate what we can detect and what we are missing from 
genome-wide CRISPR screens; demonstrating both the biases and blind-spots. In 
Chapter 2, I described the synthetic genome modeling approach that addresses the 
basic question of how many essential genes we expect to detect and what the error 
rate is in an average monogenic knockout screen. This analysis is especially important 
for establishing the expectations and limitations of the results from a typical screen. In 
contrast to big projects such as the DepMap or Project Score, we and many other labs 
do not typically screen hundreds of cell lines / replicates for an individual experiment. 
 165 
Instead, we perform the screens with a limited number of replicates and therefore it is 
crucial to establish a baseline rate for these screens while interpreting the results. 
Fortunately, the synthetic genome model resulted in a similar trend in both the Avana 
and Sanger datasets, indicating that our method is not biased towards the library used 
to screen the cell lines. In the same chapter, I also introduced our saturation modeling 
approach which can identify high confidence essential genes in a given tissue type 
using data from the DepMap data. As a continuation of the synthetic genome model 
which gives us the expected number of essentials and the error rate in a screen, the 
saturation model separates the actual essential genes from the false positives. With 
this method, I updated our daisy model of essentiality with a new set of core essential 
genes that are expected to be essential across all contexts. This extensive set of core 
essential genes captures additional genes responsible for indispensable processes of 
the cell, therefore it can serve as a better yardstick to evaluate screen qualities and 
as a new gold standard set for the BAGEL algorithm. Surprisingly, the context 
essential genes in different tissue types highly overlap and that tissue specific context 
essentials are actually very rare. Regardless, these uniquely context specific 
essentials include many tissue specific transcription factors which define pathways of 
tissue specific differentiation. Another important observation from these analyses is 
that there is a bias towards moderately expressed genes and that each screen comes 
with a ~20% false negative rate, which represents an unknown set of essential genes 
that we are failing to detect in these screens.  
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In Chapter 3, I addressed this false negative problem described in the previous 
chapter by developing the adjusted priors method that uses the information generated 
from the saturation modeling approach to rescue the false negatives in the data. With 
this approach, a substantial number of false negatives are rescued in both the Avana 
and Sanger datasets, which increases the concordance of hits between the two 
approaches. Moreover, adjusted priors can also be used to detect subtypes of cancer 
cell lines which display differential essentiality for groups of genes that show functional 
coherence.  
 
After discussing all the information we are able to detect from CRISPR screens, 
Chapter 4 reveals a major source for a blind-spot in these monogenic knockout 
screens. While searching for an answer to why we detect so few essential genes in 
these screens, I observed that almost half of all constitutively expressed genes are 
not observed as essential in any monogenic knockout screen. Furthermore, these 
never essentials are much more likely than common essentials to have paralogs which 
indicates that their phenotypes are being masked due to functional buffering. We 
tested this idea with the enCas12a system to perform dual knockouts of candidate 
paralog pairs to identify multiple synthetic lethal interactions, indicating that multiplex 
perturbations can reveal cancer specific dependencies that are invisible in monogenic 
knockout screening efforts. 
 
Collectively, in this thesis, I demonstrated the biases and blind-spots that were 
spotted during our efforts to identify cancer-specific vulnerabilities from monogenic 
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CRISPR-Cas9 knockout screens in heterogeneous sets of human cancer cell lines. 
While the monogenic CRISPR screens have been extensively used to elucidate gene 
function and to identify tumor specific weaknesses for potential therapeutic targeting, 
they are insufficient to detect all genomic vulnerabilities in cancer cell lines. An 
important gap we observed is that the single gene knockout screens are unable to 
identify all cancer-specific genomic dependencies due to functional redundancy of the 
paralog pairs. Although our work serves as a proof of concept for the capabilities of 
enCas12a technology to achieve dual gene knockouts and identify paralog 
dependencies based on double gene knockouts, future experiments are needed to 
discover the complete catalog of paralog synthetic lethality. These experiments can 
focus on testing more paralog pairs and in different genetic backgrounds since as we 
have shown, synthetic lethality can also be context dependent. With these efforts, 
more data will be generated to study features which can be used to predict paralog 
synthetic lethality. We have evaluated features such as sequence similarity, co-
expression, co-essentiality, etc. to develop a logistic regression model to predict which 
paralogs are more likely to be synthetic lethal (not discussed in this thesis). However 
these models were limited due to the rarity of the synthetic lethal paralog pairs, 
creating a class imbalance problem as well as due to lack of extensive training set 
data. Testing of more comprehensive set of paralog synthetic lethal relationships in 
different genetic backgrounds can address these problems towards the development 
of a predictive model of paralog synthetic lethality.  
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  Another limitation of our work is that we focused on only one to one paralogous 
relationships with our dual enCas12a system but there are hundreds of paralog gene 
families with more than two members. Fortunately, enCas12a system can be used to 
efficiently generate simultaneous knockouts of multiple gene combinations instead of 
just double knockouts to address these research questions.  
 
Besides testing hypotheses related to paralog synthetic lethality, enCas12a 
system can be utilized to identify a more comprehensive set of genetic interactions 
and synthetic lethality across all genes in tumors. As I discussed above, human body 
can be conceived as a big system of systems and therefore diseases like cancer 
dysregulate and rewire the usual hierarchical organization of these systems. 
enCas12a platform can be utilized to study multiplex genetic perturbations as it 
happens in cancer, in order to identify emergent vulnerabilities when the pathways are 
rewired. In addition to studying gene to gene interactions, enCas12a system can also 
be used to create a multiplex perturbation platform to screen and model drug response 
in patient tumor cells. Our observations in monogenic Cas9 knockout screens have 
shown that these screens are unable to predict drug response when a cancer drug 
targets a paralog gene family. By designing reagents that phenocopy drug activity with 
enCas12a system, we can conduct screens in parallel with the drug treatment in order 
to evaluate drug response to specific tumors. This idea can be applied to actual 
patients’ tumors through in vivo screens which can advance precision medicine, 
bringing us a step closer to identifying the unique vulnerabilities in a personalized 
manner, matching the right patients with the right drugs. 
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Finally, it is evident that capturing the complexity of the human cell and its 
interactions with its environment is highly dependent on our technological ability to 
model the system and detect the cellular adaptations to perturbations. Although 
monogenic Cas9 knockout screens or dual enCas12a screens can offer important 
insights into tumor specific gene essentiality, further technological advancements are 
needed to develop efficient platforms that are capable of accurately quantifying 
responses of multiplex genetic perturbations while modeling the complex organization 
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